Gene Symbol | Gene ID | Gene Info |
---|---|---|
Smarcc1
|
ENSMUSG00000032481.10 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 |
Fosl1
|
ENSMUSG00000024912.5 | fos-like antigen 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr19_5447405_5448723 | Fosl1 | 143 | 0.838347 | -0.32 | 1.3e-02 | Click! |
chr19_5451503_5451764 | Fosl1 | 3712 | 0.061035 | -0.29 | 2.3e-02 | Click! |
chr19_5445136_5445287 | Fosl1 | 2336 | 0.081594 | -0.17 | 1.9e-01 | Click! |
chr19_5451787_5451938 | Fosl1 | 3941 | 0.059393 | -0.14 | 2.9e-01 | Click! |
chr19_5448776_5449095 | Fosl1 | 1014 | 0.206000 | 0.12 | 3.4e-01 | Click! |
chr9_110206154_110206305 | Smarcc1 | 20497 | 0.128307 | -0.29 | 2.4e-02 | Click! |
chr9_110133939_110134205 | Smarcc1 | 2035 | 0.245070 | -0.25 | 5.5e-02 | Click! |
chr9_110205981_110206132 | Smarcc1 | 20324 | 0.128695 | -0.24 | 6.5e-02 | Click! |
chr9_110134229_110134382 | Smarcc1 | 2268 | 0.226167 | -0.24 | 7.1e-02 | Click! |
chr9_110134561_110134712 | Smarcc1 | 2599 | 0.206567 | -0.22 | 8.5e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr9_44340460_44342952 | 21.96 |
Hmbs |
hydroxymethylbilane synthase |
473 |
0.51 |
chr7_45523041_45524800 | 19.93 |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
151 |
0.85 |
chr7_99594627_99596228 | 17.07 |
Arrb1 |
arrestin, beta 1 |
804 |
0.48 |
chr11_97439854_97442222 | 15.70 |
Arhgap23 |
Rho GTPase activating protein 23 |
4753 |
0.18 |
chr10_62341499_62342686 | 15.52 |
Hk1 |
hexokinase 1 |
607 |
0.63 |
chr8_123980583_123981049 | 14.89 |
Abcb10 |
ATP-binding cassette, sub-family B (MDR/TAP), member 10 |
2306 |
0.17 |
chr11_87756102_87757558 | 14.56 |
Mir142 |
microRNA 142 |
34 |
0.59 |
chr8_23034845_23035677 | 14.47 |
Ank1 |
ankyrin 1, erythroid |
30 |
0.98 |
chr2_173024069_173026002 | 14.04 |
Rbm38 |
RNA binding motif protein 38 |
1985 |
0.21 |
chr4_115059803_115061295 | 13.98 |
Tal1 |
T cell acute lymphocytic leukemia 1 |
1041 |
0.47 |
chr8_84836764_84838739 | 13.98 |
Rad23a |
RAD23 homolog A, nucleotide excision repair protein |
296 |
0.75 |
chr17_33712070_33712674 | 13.88 |
Marchf2 |
membrane associated ring-CH-type finger 2 |
1009 |
0.36 |
chr11_97434598_97436859 | 13.74 |
Arhgap23 |
Rho GTPase activating protein 23 |
557 |
0.73 |
chr8_71702224_71703093 | 13.10 |
B3gnt3 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 |
869 |
0.35 |
chr7_143007094_143009025 | 12.99 |
Tspan32os |
tetraspanin 32, opposite strand |
26 |
0.96 |
chr2_35334268_35334953 | 12.89 |
Stom |
stomatin |
2366 |
0.21 |
chr7_78913499_78914279 | 12.83 |
Isg20 |
interferon-stimulated protein |
92 |
0.95 |
chr8_120292266_120293650 | 12.81 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
64502 |
0.09 |
chr8_84191880_84193219 | 12.71 |
Gm26887 |
predicted gene, 26887 |
5118 |
0.06 |
chr18_62176067_62177775 | 12.59 |
Adrb2 |
adrenergic receptor, beta 2 |
3038 |
0.24 |
chr1_130731543_130732516 | 12.48 |
AA986860 |
expressed sequence AA986860 |
53 |
0.94 |
chr9_48338929_48340200 | 12.46 |
Nxpe2 |
neurexophilin and PC-esterase domain family, member 2 |
1270 |
0.48 |
chr7_99824758_99826479 | 12.22 |
Neu3 |
neuraminidase 3 |
2799 |
0.17 |
chr1_58970537_58971332 | 12.13 |
Trak2 |
trafficking protein, kinesin binding 2 |
2495 |
0.2 |
chr7_100494865_100496416 | 11.95 |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
439 |
0.68 |
chr4_154024404_154026596 | 11.91 |
Smim1 |
small integral membrane protein 1 |
116 |
0.93 |
chr12_111445027_111446639 | 11.86 |
Tnfaip2 |
tumor necrosis factor, alpha-induced protein 2 |
251 |
0.87 |
chr7_133700764_133701966 | 11.80 |
Uros |
uroporphyrinogen III synthase |
1173 |
0.35 |
chr8_122546551_122549259 | 11.55 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
3424 |
0.12 |
chr19_5724785_5726881 | 11.42 |
Ehbp1l1 |
EH domain binding protein 1-like 1 |
437 |
0.54 |
chr17_71205988_71206421 | 11.42 |
Lpin2 |
lipin 2 |
1528 |
0.36 |
chrX_85613609_85614890 | 11.39 |
Gm44378 |
predicted gene, 44378 |
25272 |
0.18 |
chr3_103130259_103130869 | 11.32 |
Dennd2c |
DENN/MADD domain containing 2C |
3008 |
0.18 |
chr11_82845042_82846306 | 11.32 |
Rffl |
ring finger and FYVE like domain containing protein |
418 |
0.75 |
chr8_80494890_80495139 | 11.13 |
Gypa |
glycophorin A |
1233 |
0.53 |
chr5_139389842_139390378 | 10.82 |
Gpr146 |
G protein-coupled receptor 146 |
325 |
0.81 |
chr1_133797890_133798199 | 10.81 |
Atp2b4 |
ATPase, Ca++ transporting, plasma membrane 4 |
2992 |
0.19 |
chr2_105125289_105128976 | 10.78 |
Wt1 |
Wilms tumor 1 homolog |
78 |
0.91 |
chr1_75217955_75219308 | 10.71 |
Tuba4a |
tubulin, alpha 4A |
7 |
0.92 |
chr17_29493756_29495031 | 10.69 |
Pim1 |
proviral integration site 1 |
986 |
0.37 |
chr8_94984127_94985009 | 10.66 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
98 |
0.95 |
chr2_85060620_85061523 | 10.62 |
Tnks1bp1 |
tankyrase 1 binding protein 1 |
107 |
0.95 |
chr3_137980299_137981827 | 10.54 |
Dapp1 |
dual adaptor for phosphotyrosine and 3-phosphoinositides 1 |
467 |
0.74 |
chr7_45920062_45921322 | 10.50 |
Emp3 |
epithelial membrane protein 3 |
159 |
0.87 |
chr9_66988141_66989423 | 10.47 |
Gm24225 |
predicted gene, 24225 |
7597 |
0.16 |
chr6_55336550_55338274 | 10.43 |
Aqp1 |
aquaporin 1 |
980 |
0.5 |
chr6_86078066_86079298 | 10.39 |
Add2 |
adducin 2 (beta) |
598 |
0.65 |
chr4_156254311_156255909 | 10.20 |
Samd11 |
sterile alpha motif domain containing 11 |
106 |
0.87 |
chr19_5724002_5724609 | 10.19 |
Ehbp1l1 |
EH domain binding protein 1-like 1 |
1965 |
0.11 |
chr8_70841499_70842327 | 10.19 |
Arrdc2 |
arrestin domain containing 2 |
2193 |
0.13 |
chr3_86798542_86798784 | 9.95 |
Dclk2 |
doublecortin-like kinase 2 |
497 |
0.81 |
chr10_62326596_62327258 | 9.94 |
Hk1 |
hexokinase 1 |
840 |
0.58 |
chr3_89136417_89137539 | 9.91 |
Pklr |
pyruvate kinase liver and red blood cell |
355 |
0.69 |
chr17_40813775_40814352 | 9.91 |
Rhag |
Rhesus blood group-associated A glycoprotein |
2879 |
0.21 |
chr10_115817324_115818606 | 9.79 |
Tspan8 |
tetraspanin 8 |
681 |
0.78 |
chr15_76242501_76243437 | 9.78 |
Parp10 |
poly (ADP-ribose) polymerase family, member 10 |
451 |
0.59 |
chr2_28620746_28622145 | 9.72 |
Gfi1b |
growth factor independent 1B |
500 |
0.68 |
chr5_108674592_108675616 | 9.65 |
Slc26a1 |
solute carrier family 26 (sulfate transporter), member 1 |
319 |
0.8 |
chr5_73190710_73191316 | 9.59 |
Gm42571 |
predicted gene 42571 |
596 |
0.5 |
chr1_87620304_87621692 | 9.58 |
Inpp5d |
inositol polyphosphate-5-phosphatase D |
371 |
0.85 |
chr2_148043571_148045987 | 9.48 |
Foxa2 |
forkhead box A2 |
685 |
0.65 |
chr4_135727528_135728972 | 9.45 |
Il22ra1 |
interleukin 22 receptor, alpha 1 |
78 |
0.96 |
chr6_41701642_41702158 | 9.42 |
Kel |
Kell blood group |
2439 |
0.19 |
chr16_18429039_18430122 | 9.39 |
Txnrd2 |
thioredoxin reductase 2 |
655 |
0.54 |
chr10_81497570_81499812 | 9.36 |
S1pr4 |
sphingosine-1-phosphate receptor 4 |
1441 |
0.16 |
chr1_88407096_88408235 | 9.35 |
Spp2 |
secreted phosphoprotein 2 |
259 |
0.91 |
chr11_102360845_102363484 | 9.33 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
1540 |
0.24 |
chr19_32209821_32211372 | 9.29 |
Sgms1 |
sphingomyelin synthase 1 |
417 |
0.79 |
chr2_84936571_84938205 | 9.26 |
Slc43a3 |
solute carrier family 43, member 3 |
498 |
0.71 |
chr2_167042371_167043481 | 9.24 |
Znfx1 |
zinc finger, NFX1-type containing 1 |
569 |
0.58 |
chr17_85686512_85689764 | 9.23 |
Six2 |
sine oculis-related homeobox 2 |
116 |
0.96 |
chr7_143005720_143007083 | 9.18 |
Tspan32 |
tetraspanin 32 |
473 |
0.68 |
chr7_4629257_4630354 | 9.16 |
Tmem86b |
transmembrane protein 86B |
382 |
0.66 |
chr1_37478065_37479166 | 9.10 |
4930594C11Rik |
RIKEN cDNA 4930594C11 gene |
9990 |
0.14 |
chr19_34253411_34255499 | 8.94 |
Acta2 |
actin, alpha 2, smooth muscle, aorta |
225 |
0.92 |
chr10_4611597_4612860 | 8.94 |
Esr1 |
estrogen receptor 1 (alpha) |
207 |
0.95 |
chr5_113983999_113984439 | 8.93 |
Ssh1 |
slingshot protein phosphatase 1 |
5524 |
0.14 |
chr8_104962508_104963341 | 8.92 |
Ces2g |
carboxylesterase 2G |
1149 |
0.31 |
chr5_35160468_35161280 | 8.91 |
Lrpap1 |
low density lipoprotein receptor-related protein associated protein 1 |
55108 |
0.11 |
chr6_38341600_38342409 | 8.90 |
Zc3hav1 |
zinc finger CCCH type, antiviral 1 |
12269 |
0.13 |
chr10_77210976_77211783 | 8.89 |
Col18a1 |
collagen, type XVIII, alpha 1 |
44831 |
0.11 |
chr16_92823721_92823976 | 8.89 |
Runx1 |
runt related transcription factor 1 |
1930 |
0.42 |
chr19_7018033_7019009 | 8.85 |
Fermt3 |
fermitin family member 3 |
824 |
0.38 |
chr11_78072614_78073453 | 8.83 |
Mir144 |
microRNA 144 |
28 |
0.51 |
chr13_41018072_41019454 | 8.80 |
Tmem14c |
transmembrane protein 14C |
2471 |
0.18 |
chr2_9882196_9886301 | 8.77 |
9230102O04Rik |
RIKEN cDNA 9230102O04 gene |
255 |
0.84 |
chr10_68156328_68157069 | 8.77 |
Arid5b |
AT rich interactive domain 5B (MRF1-like) |
20072 |
0.24 |
chr11_102375456_102376872 | 8.76 |
Bloodlinc |
Bloodlinc, erythroid developmental long intergenic non-protein coding transcript |
856 |
0.42 |
chr7_19082814_19086200 | 8.76 |
Dmpk |
dystrophia myotonica-protein kinase |
203 |
0.83 |
chr5_91850572_91850781 | 8.72 |
Gm5558 |
predicted gene 5558 |
43603 |
0.1 |
chr3_138130180_138131364 | 8.71 |
Mttp |
microsomal triglyceride transfer protein |
605 |
0.65 |
chrX_137118132_137120673 | 8.69 |
Esx1 |
extraembryonic, spermatogenesis, homeobox 1 |
769 |
0.36 |
chr15_102002686_102004263 | 8.67 |
Gm36026 |
predicted gene, 36026 |
738 |
0.42 |
chr18_32557788_32558922 | 8.64 |
Gypc |
glycophorin C |
1625 |
0.41 |
chr5_120138122_120139268 | 8.57 |
Gm10390 |
predicted gene 10390 |
566 |
0.77 |
chr5_113973724_113975031 | 8.57 |
Ssh1 |
slingshot protein phosphatase 1 |
7621 |
0.13 |
chr18_80169288_80170029 | 8.43 |
Gm7447 |
predicted gene 7447 |
6906 |
0.09 |
chr13_55327719_55328813 | 8.41 |
Mxd3 |
Max dimerization protein 3 |
1086 |
0.34 |
chr2_28617937_28618205 | 8.38 |
Gfi1b |
growth factor independent 1B |
2666 |
0.16 |
chr15_77754933_77755315 | 8.35 |
Apol8 |
apolipoprotein L 8 |
115 |
0.93 |
chr7_105762080_105763247 | 8.29 |
Gm15645 |
predicted gene 15645 |
342 |
0.76 |
chr5_112324659_112325247 | 8.28 |
Tfip11 |
tuftelin interacting protein 11 |
1405 |
0.26 |
chr8_84703616_84705950 | 8.27 |
Nfix |
nuclear factor I/X |
2933 |
0.13 |
chr5_86903726_86904465 | 8.24 |
Ugt2b34 |
UDP glucuronosyltransferase 2 family, polypeptide B34 |
2842 |
0.15 |
chr16_58673183_58673392 | 8.23 |
Cpox |
coproporphyrinogen oxidase |
849 |
0.5 |
chr8_117701899_117703135 | 8.22 |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
430 |
0.77 |
chr7_128523279_128524917 | 8.22 |
Bag3 |
BCL2-associated athanogene 3 |
482 |
0.7 |
chr4_142017816_142018715 | 8.22 |
4930455G09Rik |
RIKEN cDNA 4930455G09 gene |
367 |
0.8 |
chrX_143825863_143827628 | 8.21 |
Capn6 |
calpain 6 |
587 |
0.46 |
chr7_110773542_110774597 | 8.16 |
Ampd3 |
adenosine monophosphate deaminase 3 |
175 |
0.93 |
chr15_103250315_103251530 | 8.16 |
Nfe2 |
nuclear factor, erythroid derived 2 |
543 |
0.62 |
chr15_83432069_83433241 | 8.16 |
Pacsin2 |
protein kinase C and casein kinase substrate in neurons 2 |
160 |
0.94 |
chr19_29067731_29067904 | 8.09 |
Gm9895 |
predicted gene 9895 |
470 |
0.71 |
chr11_77800451_77802048 | 8.08 |
Myo18a |
myosin XVIIIA |
49 |
0.97 |
chr1_24107330_24108438 | 8.07 |
Gm37580 |
predicted gene, 37580 |
7259 |
0.18 |
chr11_95340605_95340882 | 8.03 |
Fam117a |
family with sequence similarity 117, member A |
781 |
0.51 |
chr19_29068022_29068464 | 8.01 |
Gm9895 |
predicted gene 9895 |
896 |
0.45 |
chr4_134865486_134865749 | 7.98 |
Rhd |
Rh blood group, D antigen |
1081 |
0.48 |
chr7_75612178_75613652 | 7.97 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
631 |
0.75 |
chr5_121833321_121834947 | 7.93 |
1700008B11Rik |
RIKEN cDNA 1700008B11 gene |
1061 |
0.33 |
chr16_49774016_49775107 | 7.92 |
Gm15518 |
predicted gene 15518 |
24309 |
0.2 |
chr14_118883156_118884091 | 7.90 |
Dzip1 |
DAZ interacting protein 1 |
125 |
0.95 |
chr17_36869615_36870619 | 7.88 |
Trim10 |
tripartite motif-containing 10 |
543 |
0.55 |
chr15_83593044_83593682 | 7.87 |
Ttll12 |
tubulin tyrosine ligase-like family, member 12 |
1794 |
0.26 |
chr5_107874374_107875235 | 7.84 |
Evi5 |
ecotropic viral integration site 5 |
240 |
0.86 |
chr4_46040988_46042013 | 7.84 |
Tmod1 |
tropomodulin 1 |
2291 |
0.3 |
chr13_51647097_51647471 | 7.82 |
Gm22806 |
predicted gene, 22806 |
915 |
0.49 |
chr11_117781529_117781854 | 7.82 |
Tmc8 |
transmembrane channel-like gene family 8 |
385 |
0.5 |
chr1_125676834_125678312 | 7.78 |
Gpr39 |
G protein-coupled receptor 39 |
578 |
0.8 |
chr18_75021648_75022624 | 7.75 |
Gm27781 |
predicted gene, 27781 |
1720 |
0.19 |
chr6_113690658_113691420 | 7.75 |
Irak2 |
interleukin-1 receptor-associated kinase 2 |
294 |
0.72 |
chr10_94545272_94546349 | 7.72 |
Tmcc3 |
transmembrane and coiled coil domains 3 |
379 |
0.87 |
chr16_92824962_92826063 | 7.70 |
Runx1 |
runt related transcription factor 1 |
266 |
0.94 |
chr14_32145330_32145989 | 7.67 |
Msmb |
beta-microseminoprotein |
1928 |
0.21 |
chr7_45134316_45136627 | 7.66 |
Flt3l |
FMS-like tyrosine kinase 3 ligand |
526 |
0.33 |
chr6_41702817_41703169 | 7.66 |
Kel |
Kell blood group |
1346 |
0.32 |
chr5_65863575_65864152 | 7.64 |
Rhoh |
ras homolog family member H |
245 |
0.86 |
chr10_62327314_62328305 | 7.60 |
Hk1 |
hexokinase 1 |
42 |
0.97 |
chr3_84477728_84478854 | 7.59 |
Fhdc1 |
FH2 domain containing 1 |
691 |
0.74 |
chr15_99029361_99031026 | 7.58 |
Tuba1c |
tubulin, alpha 1C |
128 |
0.92 |
chr6_5255342_5256653 | 7.57 |
Pon3 |
paraoxonase 3 |
217 |
0.93 |
chr6_83068298_83071797 | 7.57 |
Tlx2 |
T cell leukemia, homeobox 2 |
178 |
0.81 |
chr8_84741754_84745977 | 7.56 |
G430095P16Rik |
RIKEN cDNA G430095P16 gene |
20858 |
0.09 |
chr18_78122352_78123104 | 7.56 |
Slc14a1 |
solute carrier family 14 (urea transporter), member 1 |
603 |
0.79 |
chr6_55338294_55340060 | 7.54 |
Aqp1 |
aquaporin 1 |
2745 |
0.22 |
chr5_67815409_67815775 | 7.49 |
Atp8a1 |
ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1 |
261 |
0.89 |
chr17_28007198_28009699 | 7.47 |
Anks1 |
ankyrin repeat and SAM domain containing 1 |
1103 |
0.37 |
chr2_79257648_79258440 | 7.46 |
Itga4 |
integrin alpha 4 |
2097 |
0.38 |
chr9_107975554_107976970 | 7.45 |
Uba7 |
ubiquitin-like modifier activating enzyme 7 |
46 |
0.91 |
chrX_103479028_103479792 | 7.44 |
Xist |
inactive X specific transcripts |
3844 |
0.1 |
chr12_59095360_59096062 | 7.44 |
Mia2 |
MIA SH3 domain ER export factor 2 |
88 |
0.93 |
chr10_77530297_77531905 | 7.43 |
Itgb2 |
integrin beta 2 |
721 |
0.57 |
chr17_57227821_57228041 | 7.43 |
C3 |
complement component 3 |
72 |
0.95 |
chr12_95693703_95697493 | 7.41 |
Flrt2 |
fibronectin leucine rich transmembrane protein 2 |
241 |
0.92 |
chr9_107589609_107590094 | 7.39 |
Ifrd2 |
interferon-related developmental regulator 2 |
585 |
0.39 |
chr11_75165245_75169157 | 7.35 |
Hic1 |
hypermethylated in cancer 1 |
945 |
0.35 |
chr12_111943340_111944555 | 7.34 |
5033406O09Rik |
RIKEN cDNA 5033406O09 gene |
199 |
0.89 |
chr7_120879515_120880256 | 7.33 |
Eef2k |
eukaryotic elongation factor-2 kinase |
3665 |
0.15 |
chr4_152447653_152448768 | 7.33 |
Kcnab2 |
potassium voltage-gated channel, shaker-related subfamily, beta member 2 |
531 |
0.76 |
chr1_74295387_74296968 | 7.31 |
Tmbim1 |
transmembrane BAX inhibitor motif containing 1 |
482 |
0.41 |
chr14_66279066_66281333 | 7.30 |
Ptk2b |
PTK2 protein tyrosine kinase 2 beta |
783 |
0.61 |
chr18_15345788_15346105 | 7.30 |
A830021F12Rik |
RIKEN cDNA A830021F12 gene |
5988 |
0.22 |
chr7_127767459_127768302 | 7.27 |
Orai3 |
ORAI calcium release-activated calcium modulator 3 |
1935 |
0.14 |
chr6_31658772_31659222 | 7.25 |
Gm43154 |
predicted gene 43154 |
4895 |
0.2 |
chr7_120173917_120175138 | 7.24 |
Anks4b |
ankyrin repeat and sterile alpha motif domain containing 4B |
669 |
0.61 |
chr1_130732649_130733832 | 7.22 |
AA986860 |
expressed sequence AA986860 |
1130 |
0.29 |
chr8_14890439_14890780 | 7.22 |
Cln8 |
CLN8 transmembrane ER and ERGIC protein |
1250 |
0.46 |
chr5_117133717_117134877 | 7.22 |
Taok3 |
TAO kinase 3 |
656 |
0.62 |
chr6_31125380_31126701 | 7.20 |
5330406M23Rik |
RIKEN cDNA 5330406M23 gene |
15120 |
0.11 |
chr12_103656514_103657055 | 7.19 |
Serpina6 |
serine (or cysteine) peptidase inhibitor, clade A, member 6 |
318 |
0.81 |
chr17_25221667_25222954 | 7.18 |
Unkl |
unkempt family like zinc finger |
229 |
0.84 |
chr11_100735674_100736591 | 7.16 |
Rab5c |
RAB5C, member RAS oncogene family |
2044 |
0.17 |
chr6_90324065_90325476 | 7.16 |
Chst13 |
carbohydrate sulfotransferase 13 |
415 |
0.73 |
chr11_117989586_117990368 | 7.13 |
Pgs1 |
phosphatidylglycerophosphate synthase 1 |
3092 |
0.19 |
chr1_130734221_130734966 | 7.11 |
AA986860 |
expressed sequence AA986860 |
2483 |
0.14 |
chr14_27000422_27001594 | 7.10 |
Hesx1 |
homeobox gene expressed in ES cells |
646 |
0.71 |
chr18_35847749_35850271 | 7.08 |
Cxxc5 |
CXXC finger 5 |
5677 |
0.11 |
chr9_22131114_22132438 | 7.05 |
Acp5 |
acid phosphatase 5, tartrate resistant |
39 |
0.93 |
chr1_174172489_174172792 | 7.04 |
Spta1 |
spectrin alpha, erythrocytic 1 |
136 |
0.92 |
chr10_43594103_43594363 | 7.02 |
F930017D23Rik |
RIKEN cDNA F930017D23 gene |
794 |
0.55 |
chr11_102364387_102365146 | 7.00 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
481 |
0.67 |
chr8_23048168_23048944 | 7.00 |
Ank1 |
ankyrin 1, erythroid |
9703 |
0.17 |
chr1_132366786_132367836 | 7.00 |
Tmcc2 |
transmembrane and coiled-coil domains 2 |
239 |
0.89 |
chr8_105822112_105822566 | 6.99 |
Ranbp10 |
RAN binding protein 10 |
4866 |
0.1 |
chr14_19708369_19709189 | 6.99 |
Gm49341 |
predicted gene, 49341 |
11570 |
0.13 |
chr11_53422380_53423106 | 6.99 |
Leap2 |
liver-expressed antimicrobial peptide 2 |
427 |
0.66 |
chr16_8810976_8811127 | 6.98 |
Usp7 |
ubiquitin specific peptidase 7 |
18743 |
0.15 |
chr4_57914999_57916744 | 6.98 |
D630039A03Rik |
RIKEN cDNA D630039A03 gene |
426 |
0.84 |
chr15_12193885_12195324 | 6.97 |
Gm49240 |
predicted gene, 49240 |
2015 |
0.19 |
chr4_134868590_134868926 | 6.97 |
Rhd |
Rh blood group, D antigen |
4222 |
0.19 |
chr4_132072958_132073606 | 6.92 |
Epb41 |
erythrocyte membrane protein band 4.1 |
1185 |
0.28 |
chr9_58246669_58247815 | 6.92 |
Pml |
promyelocytic leukemia |
2381 |
0.19 |
chr16_93363663_93363907 | 6.91 |
1810053B23Rik |
RIKEN cDNA 1810053B23 gene |
1544 |
0.35 |
chr4_141746794_141747616 | 6.90 |
Agmat |
agmatine ureohydrolase (agmatinase) |
533 |
0.68 |
chr11_62005417_62006894 | 6.90 |
Specc1 |
sperm antigen with calponin homology and coiled-coil domains 1 |
805 |
0.61 |
chr16_95456632_95459094 | 6.88 |
Erg |
ETS transcription factor |
1382 |
0.55 |
chr15_9074646_9075526 | 6.86 |
Nadk2 |
NAD kinase 2, mitochondrial |
191 |
0.96 |
chr9_21961394_21962913 | 6.84 |
Epor |
erythropoietin receptor |
411 |
0.68 |
chr7_24369840_24369991 | 6.83 |
Kcnn4 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
348 |
0.74 |
chr3_83026692_83027527 | 6.82 |
Fga |
fibrinogen alpha chain |
894 |
0.5 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.5 | 28.5 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
9.4 | 28.1 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
7.2 | 7.2 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
7.1 | 21.4 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
6.7 | 20.1 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
6.1 | 30.5 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
5.6 | 16.9 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
5.1 | 127.3 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
5.1 | 15.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
5.0 | 25.1 | GO:0071918 | urea transmembrane transport(GO:0071918) |
4.7 | 19.0 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
4.7 | 18.7 | GO:1900200 | mesenchymal cell apoptotic process involved in metanephros development(GO:1900200) regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900211) negative regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900212) |
4.6 | 13.7 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
4.6 | 4.6 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
4.5 | 13.6 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
4.4 | 26.4 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
4.4 | 8.7 | GO:0070295 | renal water absorption(GO:0070295) |
4.3 | 17.1 | GO:0032264 | IMP salvage(GO:0032264) |
4.3 | 12.8 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
4.2 | 8.3 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
4.0 | 16.2 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
4.0 | 12.0 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
3.9 | 11.6 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
3.9 | 15.5 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
3.8 | 15.3 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
3.8 | 18.9 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
3.7 | 11.2 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
3.5 | 10.5 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
3.4 | 13.6 | GO:0050904 | diapedesis(GO:0050904) |
3.3 | 13.4 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
3.3 | 10.0 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
3.3 | 10.0 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
3.3 | 6.6 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
3.2 | 16.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
3.2 | 9.7 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
3.2 | 9.6 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
3.2 | 12.7 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
3.2 | 9.5 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
3.1 | 9.4 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
3.1 | 12.4 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
3.1 | 12.4 | GO:0070627 | ferrous iron import(GO:0070627) ferrous iron import into cell(GO:0097460) |
3.1 | 18.6 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
3.0 | 9.1 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
3.0 | 12.1 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
3.0 | 12.0 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
3.0 | 9.0 | GO:0048769 | sarcomerogenesis(GO:0048769) |
3.0 | 9.0 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
3.0 | 14.8 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
3.0 | 11.9 | GO:0070836 | caveola assembly(GO:0070836) |
2.9 | 14.5 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
2.9 | 26.0 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
2.8 | 8.5 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
2.8 | 8.5 | GO:0008228 | opsonization(GO:0008228) |
2.8 | 8.4 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
2.8 | 8.4 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
2.8 | 5.5 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
2.7 | 11.0 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
2.7 | 8.1 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
2.7 | 5.4 | GO:0035754 | B cell chemotaxis(GO:0035754) |
2.7 | 8.1 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
2.7 | 5.4 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
2.6 | 10.4 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
2.6 | 7.7 | GO:0036394 | amylase secretion(GO:0036394) |
2.5 | 7.6 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
2.5 | 7.6 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
2.5 | 7.6 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
2.5 | 7.6 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
2.5 | 17.4 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
2.5 | 9.9 | GO:0001803 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
2.5 | 9.9 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
2.5 | 4.9 | GO:0048793 | pronephros development(GO:0048793) |
2.5 | 12.3 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
2.4 | 7.3 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
2.4 | 2.4 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
2.4 | 9.5 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
2.4 | 4.7 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
2.3 | 7.0 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
2.3 | 4.6 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
2.3 | 6.9 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) |
2.3 | 9.2 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
2.3 | 6.9 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
2.3 | 4.6 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
2.3 | 6.8 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
2.3 | 6.8 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
2.3 | 6.8 | GO:0002432 | granuloma formation(GO:0002432) |
2.3 | 9.0 | GO:0071316 | cellular response to nicotine(GO:0071316) |
2.3 | 4.5 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
2.2 | 9.0 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
2.2 | 2.2 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
2.2 | 4.4 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
2.2 | 4.4 | GO:0001955 | blood vessel maturation(GO:0001955) |
2.2 | 6.6 | GO:0035483 | gastric emptying(GO:0035483) |
2.2 | 6.6 | GO:0051665 | membrane raft localization(GO:0051665) |
2.2 | 10.9 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
2.2 | 6.5 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
2.2 | 10.8 | GO:0009115 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
2.1 | 4.3 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
2.1 | 6.4 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
2.1 | 15.0 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
2.1 | 4.3 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
2.1 | 4.3 | GO:0045764 | positive regulation of cellular amino acid metabolic process(GO:0045764) |
2.1 | 4.3 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
2.1 | 6.3 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
2.1 | 14.8 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
2.1 | 4.2 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
2.1 | 14.6 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
2.1 | 8.3 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
2.1 | 12.5 | GO:1902222 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
2.1 | 8.3 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
2.0 | 6.1 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
2.0 | 6.1 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
2.0 | 4.1 | GO:0030916 | otic vesicle formation(GO:0030916) |
2.0 | 16.1 | GO:0097286 | iron ion import(GO:0097286) |
2.0 | 4.0 | GO:0018992 | germ-line sex determination(GO:0018992) |
2.0 | 4.0 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
2.0 | 4.0 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
2.0 | 5.9 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
2.0 | 4.0 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
2.0 | 5.9 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
2.0 | 9.8 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
2.0 | 5.9 | GO:0042117 | monocyte activation(GO:0042117) |
2.0 | 5.9 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
1.9 | 3.9 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
1.9 | 1.9 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
1.9 | 5.8 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
1.9 | 5.8 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
1.9 | 5.8 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
1.9 | 1.9 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
1.9 | 7.7 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
1.9 | 5.7 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
1.9 | 11.5 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
1.9 | 7.7 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
1.9 | 5.7 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
1.9 | 13.3 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
1.9 | 13.2 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
1.9 | 3.7 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
1.9 | 14.8 | GO:0043249 | erythrocyte maturation(GO:0043249) |
1.8 | 5.5 | GO:0042908 | xenobiotic transport(GO:0042908) |
1.8 | 1.8 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
1.8 | 11.0 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
1.8 | 3.7 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
1.8 | 11.0 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
1.8 | 1.8 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
1.8 | 9.1 | GO:1904970 | brush border assembly(GO:1904970) |
1.8 | 5.5 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
1.8 | 5.5 | GO:0046618 | drug export(GO:0046618) |
1.8 | 5.3 | GO:0010587 | miRNA catabolic process(GO:0010587) |
1.8 | 5.3 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
1.8 | 7.1 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
1.8 | 10.5 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
1.8 | 5.3 | GO:0001866 | NK T cell proliferation(GO:0001866) |
1.7 | 1.7 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
1.7 | 8.7 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
1.7 | 6.9 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
1.7 | 1.7 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
1.7 | 19.0 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
1.7 | 3.4 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
1.7 | 8.5 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
1.7 | 3.4 | GO:0010915 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
1.7 | 6.8 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
1.7 | 1.7 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
1.7 | 6.8 | GO:0019532 | oxalate transport(GO:0019532) |
1.7 | 5.1 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
1.7 | 1.7 | GO:0052041 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
1.7 | 1.7 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
1.7 | 1.7 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
1.7 | 1.7 | GO:0007418 | ventral midline development(GO:0007418) |
1.7 | 5.0 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.7 | 6.6 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
1.7 | 6.6 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
1.7 | 6.6 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
1.6 | 1.6 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
1.6 | 8.2 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
1.6 | 8.2 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
1.6 | 19.6 | GO:0051601 | exocyst localization(GO:0051601) |
1.6 | 4.9 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
1.6 | 8.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
1.6 | 25.9 | GO:0000305 | response to oxygen radical(GO:0000305) |
1.6 | 8.1 | GO:0015879 | carnitine transport(GO:0015879) |
1.6 | 6.5 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
1.6 | 1.6 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
1.6 | 1.6 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
1.6 | 4.8 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
1.6 | 3.2 | GO:0060435 | bronchiole development(GO:0060435) |
1.6 | 7.9 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
1.6 | 4.8 | GO:0051917 | regulation of fibrinolysis(GO:0051917) |
1.6 | 6.3 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
1.6 | 4.7 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
1.6 | 1.6 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
1.6 | 6.3 | GO:2000391 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
1.6 | 3.1 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
1.6 | 1.6 | GO:0072039 | regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072039) negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072040) mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:1901145) regulation of somatic stem cell population maintenance(GO:1904672) negative regulation of somatic stem cell population maintenance(GO:1904673) |
1.6 | 9.4 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
1.6 | 3.1 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
1.6 | 10.9 | GO:0071318 | cellular response to ATP(GO:0071318) |
1.6 | 14.0 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
1.5 | 9.2 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
1.5 | 9.2 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
1.5 | 1.5 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
1.5 | 1.5 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
1.5 | 16.7 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
1.5 | 6.1 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
1.5 | 4.5 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
1.5 | 4.5 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
1.5 | 3.0 | GO:0023021 | termination of signal transduction(GO:0023021) |
1.5 | 7.5 | GO:0090166 | Golgi disassembly(GO:0090166) |
1.5 | 7.5 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
1.5 | 1.5 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
1.5 | 1.5 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
1.5 | 5.9 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
1.5 | 4.4 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.5 | 4.4 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
1.5 | 1.5 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
1.5 | 5.9 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
1.5 | 4.4 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
1.5 | 13.1 | GO:0070269 | pyroptosis(GO:0070269) |
1.4 | 5.8 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
1.4 | 2.9 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
1.4 | 4.3 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
1.4 | 4.3 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
1.4 | 4.3 | GO:0044805 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
1.4 | 4.3 | GO:0006083 | acetate metabolic process(GO:0006083) |
1.4 | 2.8 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
1.4 | 4.2 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
1.4 | 2.8 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
1.4 | 5.6 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
1.4 | 5.6 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
1.4 | 8.4 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
1.4 | 4.2 | GO:0015886 | heme transport(GO:0015886) |
1.4 | 4.2 | GO:0000212 | meiotic spindle organization(GO:0000212) |
1.4 | 4.1 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
1.4 | 2.8 | GO:0001555 | oocyte growth(GO:0001555) |
1.4 | 5.5 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
1.4 | 4.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
1.4 | 8.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
1.4 | 1.4 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
1.4 | 4.1 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
1.4 | 8.2 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
1.4 | 12.2 | GO:0032060 | bleb assembly(GO:0032060) |
1.4 | 1.4 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
1.4 | 17.6 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
1.3 | 2.7 | GO:0046208 | spermine catabolic process(GO:0046208) |
1.3 | 2.7 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
1.3 | 1.3 | GO:0031627 | telomeric loop formation(GO:0031627) |
1.3 | 5.3 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
1.3 | 5.3 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
1.3 | 6.6 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
1.3 | 3.9 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
1.3 | 6.5 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
1.3 | 3.9 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
1.3 | 3.9 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
1.3 | 32.5 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
1.3 | 3.9 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
1.3 | 3.9 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
1.3 | 3.9 | GO:0061010 | gall bladder development(GO:0061010) |
1.3 | 12.9 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
1.3 | 2.6 | GO:0032782 | bile acid secretion(GO:0032782) |
1.3 | 2.6 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
1.3 | 5.1 | GO:0036089 | cleavage furrow formation(GO:0036089) |
1.3 | 3.9 | GO:0015889 | cobalamin transport(GO:0015889) |
1.3 | 11.5 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
1.3 | 2.5 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
1.3 | 5.1 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
1.3 | 10.1 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
1.3 | 7.6 | GO:0060613 | fat pad development(GO:0060613) |
1.3 | 6.3 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
1.3 | 1.3 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
1.3 | 16.3 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
1.3 | 6.3 | GO:2000726 | negative regulation of cardiac muscle cell differentiation(GO:2000726) |
1.2 | 17.5 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
1.2 | 7.5 | GO:0071265 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
1.2 | 3.7 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
1.2 | 8.6 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
1.2 | 3.7 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
1.2 | 1.2 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
1.2 | 4.9 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
1.2 | 6.1 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
1.2 | 3.6 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
1.2 | 1.2 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
1.2 | 2.4 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
1.2 | 9.7 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
1.2 | 1.2 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) |
1.2 | 1.2 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
1.2 | 4.8 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
1.2 | 4.8 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
1.2 | 2.4 | GO:0036302 | atrioventricular canal development(GO:0036302) |
1.2 | 3.6 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
1.2 | 3.6 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
1.2 | 7.1 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
1.2 | 1.2 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
1.2 | 2.4 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
1.2 | 8.2 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
1.2 | 4.7 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
1.2 | 4.7 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
1.2 | 2.3 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
1.2 | 1.2 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
1.2 | 8.1 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
1.2 | 1.2 | GO:0006624 | vacuolar protein processing(GO:0006624) |
1.2 | 13.9 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
1.2 | 4.6 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
1.1 | 6.9 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
1.1 | 4.6 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
1.1 | 6.8 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
1.1 | 1.1 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
1.1 | 3.4 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
1.1 | 3.4 | GO:0035973 | aggrephagy(GO:0035973) |
1.1 | 10.2 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
1.1 | 20.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
1.1 | 9.0 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
1.1 | 1.1 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
1.1 | 3.3 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
1.1 | 3.3 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
1.1 | 2.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
1.1 | 6.6 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
1.1 | 1.1 | GO:0002159 | desmosome assembly(GO:0002159) |
1.1 | 7.7 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
1.1 | 6.6 | GO:0042730 | fibrinolysis(GO:0042730) |
1.1 | 3.3 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
1.1 | 4.4 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
1.1 | 2.2 | GO:0003166 | bundle of His development(GO:0003166) |
1.1 | 1.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.1 | 1.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
1.1 | 3.3 | GO:0032621 | interleukin-18 production(GO:0032621) |
1.1 | 4.4 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
1.1 | 6.5 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
1.1 | 7.6 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
1.1 | 14.1 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
1.1 | 2.2 | GO:0006971 | hypotonic response(GO:0006971) cellular hypotonic response(GO:0071476) |
1.1 | 2.2 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
1.1 | 2.2 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
1.1 | 5.4 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
1.1 | 3.2 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
1.1 | 2.2 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
1.1 | 3.2 | GO:0060674 | placenta blood vessel development(GO:0060674) |
1.1 | 1.1 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
1.1 | 2.1 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
1.1 | 3.2 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
1.0 | 1.0 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
1.0 | 4.2 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
1.0 | 6.3 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
1.0 | 3.1 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
1.0 | 2.1 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
1.0 | 8.3 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
1.0 | 2.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
1.0 | 2.1 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
1.0 | 4.2 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
1.0 | 4.2 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
1.0 | 8.3 | GO:0043247 | telomere maintenance in response to DNA damage(GO:0043247) |
1.0 | 1.0 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
1.0 | 20.7 | GO:0006270 | DNA replication initiation(GO:0006270) |
1.0 | 8.3 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
1.0 | 3.1 | GO:0006742 | NADP catabolic process(GO:0006742) |
1.0 | 1.0 | GO:0007494 | midgut development(GO:0007494) |
1.0 | 4.1 | GO:0042168 | heme metabolic process(GO:0042168) |
1.0 | 5.1 | GO:0044351 | macropinocytosis(GO:0044351) |
1.0 | 1.0 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
1.0 | 8.2 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
1.0 | 11.2 | GO:0007035 | vacuolar acidification(GO:0007035) |
1.0 | 4.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
1.0 | 3.0 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
1.0 | 3.0 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
1.0 | 1.0 | GO:0006203 | dGTP catabolic process(GO:0006203) |
1.0 | 12.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
1.0 | 1.0 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
1.0 | 5.0 | GO:0001842 | neural fold formation(GO:0001842) |
1.0 | 2.0 | GO:0015677 | copper ion import(GO:0015677) |
1.0 | 1.0 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
1.0 | 4.0 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
1.0 | 3.0 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
1.0 | 3.0 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
1.0 | 3.0 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
1.0 | 2.0 | GO:0072672 | neutrophil extravasation(GO:0072672) |
1.0 | 2.0 | GO:0009299 | mRNA transcription(GO:0009299) |
1.0 | 9.9 | GO:0032801 | receptor catabolic process(GO:0032801) |
1.0 | 3.0 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
1.0 | 3.0 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
1.0 | 1.0 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
1.0 | 4.0 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
1.0 | 3.0 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
1.0 | 1.0 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
1.0 | 2.0 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
1.0 | 1.0 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
1.0 | 7.8 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
1.0 | 3.9 | GO:0045332 | phospholipid translocation(GO:0045332) |
1.0 | 2.9 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
1.0 | 2.9 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
1.0 | 1.9 | GO:0070669 | response to interleukin-2(GO:0070669) |
1.0 | 3.8 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
1.0 | 1.0 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
1.0 | 1.0 | GO:0044838 | cell quiescence(GO:0044838) |
1.0 | 1.0 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
1.0 | 1.0 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
1.0 | 3.8 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
1.0 | 7.6 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
1.0 | 1.0 | GO:0072275 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
1.0 | 2.9 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.9 | 1.9 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.9 | 2.8 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.9 | 0.9 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.9 | 6.6 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.9 | 1.9 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.9 | 2.8 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.9 | 0.9 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.9 | 11.3 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.9 | 2.8 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.9 | 0.9 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.9 | 2.8 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.9 | 3.7 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.9 | 0.9 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.9 | 1.9 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.9 | 0.9 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.9 | 5.6 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.9 | 0.9 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.9 | 0.9 | GO:0045472 | response to ether(GO:0045472) |
0.9 | 0.9 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.9 | 0.9 | GO:0006848 | pyruvate transport(GO:0006848) |
0.9 | 0.9 | GO:0010965 | regulation of mitotic sister chromatid separation(GO:0010965) |
0.9 | 1.9 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.9 | 7.4 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.9 | 0.9 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.9 | 2.8 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.9 | 0.9 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.9 | 5.5 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.9 | 0.9 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.9 | 2.7 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.9 | 0.9 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
0.9 | 7.3 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.9 | 7.3 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.9 | 11.9 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.9 | 0.9 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.9 | 0.9 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.9 | 2.7 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.9 | 1.8 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) |
0.9 | 7.2 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.9 | 13.6 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.9 | 1.8 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.9 | 4.5 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.9 | 0.9 | GO:0000726 | non-recombinational repair(GO:0000726) |
0.9 | 0.9 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.9 | 2.7 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.9 | 7.2 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.9 | 0.9 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.9 | 0.9 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.9 | 8.1 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.9 | 3.6 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.9 | 2.7 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.9 | 5.3 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.9 | 7.1 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.9 | 2.7 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.9 | 4.4 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.9 | 3.5 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.9 | 4.4 | GO:0051451 | myoblast migration(GO:0051451) |
0.9 | 1.8 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.9 | 2.6 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.9 | 3.5 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.9 | 1.7 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) |
0.9 | 26.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.9 | 0.9 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.9 | 5.2 | GO:0046415 | urate metabolic process(GO:0046415) |
0.9 | 1.7 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.9 | 0.9 | GO:0015705 | iodide transport(GO:0015705) |
0.9 | 3.5 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.9 | 15.5 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.9 | 2.6 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.9 | 3.4 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.9 | 0.9 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.9 | 6.0 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.9 | 0.9 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.9 | 5.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.9 | 0.9 | GO:0033058 | directional locomotion(GO:0033058) |
0.9 | 17.0 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.9 | 0.9 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.8 | 2.5 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.8 | 0.8 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.8 | 6.8 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.8 | 1.7 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
0.8 | 1.7 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.8 | 2.5 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.8 | 6.7 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.8 | 2.5 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.8 | 1.7 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.8 | 5.0 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.8 | 0.8 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.8 | 1.7 | GO:0042424 | catechol-containing compound catabolic process(GO:0019614) dopamine catabolic process(GO:0042420) catecholamine catabolic process(GO:0042424) |
0.8 | 1.7 | GO:0019086 | late viral transcription(GO:0019086) |
0.8 | 2.5 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.8 | 5.0 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.8 | 1.7 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.8 | 2.5 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.8 | 2.5 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.8 | 0.8 | GO:0043558 | regulation of translational initiation in response to stress(GO:0043558) |
0.8 | 0.8 | GO:0071351 | response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
0.8 | 4.1 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.8 | 4.1 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.8 | 8.2 | GO:1901739 | regulation of myoblast fusion(GO:1901739) |
0.8 | 0.8 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.8 | 4.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.8 | 6.5 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.8 | 1.6 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.8 | 2.4 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.8 | 2.4 | GO:0071047 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.8 | 4.0 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.8 | 7.3 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.8 | 0.8 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.8 | 1.6 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.8 | 1.6 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.8 | 2.4 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.8 | 4.0 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.8 | 4.8 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.8 | 3.2 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.8 | 0.8 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.8 | 5.6 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.8 | 2.4 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.8 | 1.6 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.8 | 4.8 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.8 | 1.6 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.8 | 2.4 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.8 | 7.9 | GO:0048821 | erythrocyte development(GO:0048821) |
0.8 | 1.6 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.8 | 0.8 | GO:0060956 | endocardial cell differentiation(GO:0060956) |
0.8 | 2.4 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.8 | 3.1 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.8 | 1.6 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.8 | 8.6 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.8 | 3.9 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.8 | 1.6 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.8 | 3.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.8 | 7.8 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.8 | 7.8 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.8 | 0.8 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.8 | 26.4 | GO:0045576 | mast cell activation(GO:0045576) |
0.8 | 1.5 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.8 | 3.9 | GO:0018101 | protein citrullination(GO:0018101) |
0.8 | 10.1 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.8 | 5.4 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.8 | 2.3 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.8 | 0.8 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.8 | 2.3 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.8 | 2.3 | GO:2000257 | regulation of protein activation cascade(GO:2000257) |
0.8 | 7.7 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.8 | 2.3 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.8 | 2.3 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.8 | 1.5 | GO:0002215 | defense response to nematode(GO:0002215) |
0.8 | 16.1 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.8 | 3.1 | GO:0035590 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.8 | 3.8 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.8 | 19.0 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.8 | 1.5 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.8 | 6.1 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.8 | 2.3 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.8 | 1.5 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.8 | 12.8 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.8 | 19.6 | GO:0010761 | fibroblast migration(GO:0010761) |
0.8 | 3.8 | GO:0033504 | floor plate development(GO:0033504) |
0.8 | 1.5 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.7 | 3.7 | GO:0018904 | ether metabolic process(GO:0018904) |
0.7 | 5.2 | GO:0019081 | viral translation(GO:0019081) |
0.7 | 6.7 | GO:0051383 | kinetochore organization(GO:0051383) |
0.7 | 1.5 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.7 | 2.2 | GO:0009597 | detection of virus(GO:0009597) |
0.7 | 6.0 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.7 | 1.5 | GO:0060056 | mammary gland involution(GO:0060056) |
0.7 | 1.5 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.7 | 11.1 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.7 | 1.5 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.7 | 0.7 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.7 | 0.7 | GO:0072718 | response to cisplatin(GO:0072718) |
0.7 | 5.9 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.7 | 1.5 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.7 | 3.7 | GO:0007097 | nuclear migration(GO:0007097) |
0.7 | 0.7 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.7 | 3.0 | GO:0032667 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
0.7 | 0.7 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.7 | 5.9 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.7 | 2.9 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.7 | 3.7 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.7 | 3.7 | GO:0000237 | leptotene(GO:0000237) |
0.7 | 2.9 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.7 | 2.9 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.7 | 0.7 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.7 | 0.7 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.7 | 2.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.7 | 13.0 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.7 | 2.2 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.7 | 2.2 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.7 | 5.0 | GO:0055064 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.7 | 0.7 | GO:0033206 | meiotic cytokinesis(GO:0033206) |
0.7 | 0.7 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.7 | 2.2 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.7 | 0.7 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
0.7 | 9.3 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.7 | 4.9 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.7 | 9.2 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.7 | 2.1 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.7 | 0.7 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.7 | 0.7 | GO:2000515 | negative regulation of CD4-positive, alpha-beta T cell activation(GO:2000515) |
0.7 | 1.4 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.7 | 5.6 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.7 | 2.8 | GO:0018214 | protein carboxylation(GO:0018214) |
0.7 | 2.8 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.7 | 2.1 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.7 | 2.1 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.7 | 2.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.7 | 9.1 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.7 | 2.1 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.7 | 3.5 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.7 | 2.8 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.7 | 2.1 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.7 | 1.4 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.7 | 9.6 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.7 | 1.4 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.7 | 1.4 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.7 | 2.8 | GO:0032908 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
0.7 | 1.4 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.7 | 2.7 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.7 | 2.0 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.7 | 1.4 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.7 | 2.0 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.7 | 0.7 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.7 | 0.7 | GO:0044126 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.7 | 3.4 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.7 | 7.4 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.7 | 2.0 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.7 | 0.7 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.7 | 8.7 | GO:0015858 | nucleoside transport(GO:0015858) |
0.7 | 5.4 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.7 | 2.7 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.7 | 3.3 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.7 | 3.3 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.7 | 0.7 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
0.7 | 1.3 | GO:1904752 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) |
0.7 | 5.3 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.7 | 2.0 | GO:0018343 | protein farnesylation(GO:0018343) |
0.7 | 2.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.7 | 3.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.7 | 1.3 | GO:1904748 | regulation of apoptotic process involved in development(GO:1904748) |
0.7 | 2.0 | GO:0031946 | negative regulation of glucocorticoid metabolic process(GO:0031944) regulation of glucocorticoid biosynthetic process(GO:0031946) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.7 | 1.3 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.7 | 1.3 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.7 | 2.0 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.7 | 0.7 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.7 | 3.3 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.7 | 3.3 | GO:0006907 | pinocytosis(GO:0006907) |
0.7 | 2.6 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.7 | 0.7 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.7 | 2.0 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.6 | 1.3 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.6 | 2.6 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.6 | 16.8 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.6 | 5.8 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.6 | 1.3 | GO:0044818 | mitotic G2/M transition checkpoint(GO:0044818) |
0.6 | 0.6 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.6 | 1.3 | GO:0048539 | bone marrow development(GO:0048539) |
0.6 | 2.6 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.6 | 3.2 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.6 | 1.9 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.6 | 1.9 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.6 | 4.5 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.6 | 1.9 | GO:1902402 | signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.6 | 1.9 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.6 | 2.5 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.6 | 1.9 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.6 | 1.3 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.6 | 1.9 | GO:0015671 | oxygen transport(GO:0015671) |
0.6 | 4.4 | GO:0060896 | neural plate pattern specification(GO:0060896) |
0.6 | 1.9 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.6 | 1.3 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.6 | 3.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.6 | 3.1 | GO:0051168 | nuclear export(GO:0051168) |
0.6 | 9.4 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
0.6 | 1.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.6 | 0.6 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.6 | 1.9 | GO:0032570 | response to progesterone(GO:0032570) |
0.6 | 1.2 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.6 | 3.7 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.6 | 0.6 | GO:0035907 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.6 | 0.6 | GO:0019661 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.6 | 2.5 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.6 | 3.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.6 | 0.6 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.6 | 3.1 | GO:0015825 | L-serine transport(GO:0015825) |
0.6 | 0.6 | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) |
0.6 | 2.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.6 | 0.6 | GO:1902023 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.6 | 2.5 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.6 | 0.6 | GO:0052173 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.6 | 3.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.6 | 1.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.6 | 0.6 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) regulation of vascular smooth muscle cell differentiation(GO:1905063) |
0.6 | 1.2 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.6 | 2.4 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.6 | 14.0 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.6 | 3.6 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.6 | 2.4 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.6 | 2.4 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.6 | 1.2 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.6 | 0.6 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.6 | 0.6 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.6 | 6.0 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.6 | 0.6 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.6 | 0.6 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.6 | 5.4 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.6 | 4.2 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
0.6 | 2.4 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.6 | 3.0 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.6 | 8.3 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.6 | 3.6 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.6 | 2.4 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.6 | 5.3 | GO:0048535 | lymph node development(GO:0048535) |
0.6 | 4.1 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.6 | 0.6 | GO:0048382 | mesendoderm development(GO:0048382) corticotropin hormone secreting cell differentiation(GO:0060128) |
0.6 | 1.2 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.6 | 0.6 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.6 | 9.4 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.6 | 0.6 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.6 | 2.9 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.6 | 2.9 | GO:0046697 | decidualization(GO:0046697) |
0.6 | 1.2 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.6 | 0.6 | GO:1901723 | negative regulation of cell proliferation involved in kidney development(GO:1901723) |
0.6 | 3.5 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.6 | 2.3 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.6 | 1.2 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.6 | 2.3 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.6 | 0.6 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.6 | 4.0 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.6 | 0.6 | GO:0001923 | B-1 B cell differentiation(GO:0001923) B-1a B cell differentiation(GO:0002337) |
0.6 | 0.6 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.6 | 1.7 | GO:0002836 | positive regulation of response to tumor cell(GO:0002836) positive regulation of immune response to tumor cell(GO:0002839) |
0.6 | 2.3 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.6 | 2.3 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.6 | 1.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.6 | 2.8 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.6 | 9.6 | GO:0030488 | tRNA methylation(GO:0030488) |
0.6 | 1.1 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.6 | 2.8 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.6 | 1.7 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.6 | 6.6 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.6 | 0.6 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.6 | 0.6 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.6 | 1.1 | GO:1902075 | cellular response to salt(GO:1902075) |
0.6 | 1.1 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.5 | 0.5 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.5 | 0.5 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.5 | 3.8 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.5 | 1.6 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.5 | 2.1 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.5 | 1.1 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.5 | 3.7 | GO:0051693 | actin filament capping(GO:0051693) |
0.5 | 0.5 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.5 | 1.6 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.5 | 6.3 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.5 | 3.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.5 | 1.6 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.5 | 1.6 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.5 | 1.6 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.5 | 2.6 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.5 | 1.0 | GO:0044252 | negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.5 | 4.1 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.5 | 1.5 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.5 | 8.7 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.5 | 10.2 | GO:0006953 | acute-phase response(GO:0006953) |
0.5 | 0.5 | GO:1902109 | negative regulation of mitochondrial membrane permeability(GO:0035795) negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.5 | 1.0 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.5 | 1.5 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.5 | 1.0 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.5 | 3.6 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.5 | 1.5 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.5 | 1.0 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.5 | 2.5 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.5 | 1.5 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.5 | 1.0 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
0.5 | 0.5 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.5 | 2.5 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.5 | 1.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.5 | 2.0 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.5 | 2.5 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.5 | 1.0 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.5 | 2.0 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.5 | 2.0 | GO:0007296 | vitellogenesis(GO:0007296) |
0.5 | 1.0 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.5 | 1.0 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.5 | 1.5 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.5 | 2.0 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.5 | 1.5 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.5 | 3.9 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.5 | 0.5 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.5 | 3.9 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.5 | 1.4 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.5 | 0.5 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.5 | 18.2 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.5 | 0.5 | GO:0070431 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.5 | 1.0 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.5 | 5.7 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.5 | 1.4 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.5 | 15.2 | GO:0007569 | cell aging(GO:0007569) |
0.5 | 1.9 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.5 | 1.9 | GO:0070741 | response to interleukin-6(GO:0070741) cellular response to interleukin-6(GO:0071354) |
0.5 | 1.9 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.5 | 2.4 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.5 | 9.0 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.5 | 1.9 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.5 | 1.4 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.5 | 4.2 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.5 | 0.5 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.5 | 11.6 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.5 | 2.8 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.5 | 1.4 | GO:0040033 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.5 | 0.5 | GO:1905214 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.5 | 2.3 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.5 | 0.5 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.5 | 0.9 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.5 | 0.5 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.5 | 5.1 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.5 | 1.8 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.5 | 0.9 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.5 | 1.4 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.5 | 0.5 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.5 | 1.4 | GO:0044557 | relaxation of smooth muscle(GO:0044557) |
0.5 | 1.8 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.5 | 8.2 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.5 | 0.9 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.5 | 1.4 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.5 | 4.1 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.5 | 0.5 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.4 | 1.8 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.4 | 0.9 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.4 | 0.4 | GO:0055093 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.4 | 0.4 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.4 | 6.2 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.4 | 0.9 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.4 | 6.2 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.4 | 1.8 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.4 | 3.1 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.4 | 0.9 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.4 | 4.9 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.4 | 0.4 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.4 | 1.3 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.4 | 4.0 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.4 | 0.4 | GO:0072429 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.4 | 1.8 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.4 | 3.0 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.4 | 0.4 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.4 | 0.4 | GO:0032800 | receptor biosynthetic process(GO:0032800) |
0.4 | 0.4 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.4 | 0.9 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.4 | 1.3 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.4 | 0.9 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.4 | 0.4 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.4 | 1.3 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.4 | 0.4 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.4 | 3.4 | GO:0070203 | regulation of establishment of protein localization to telomere(GO:0070203) positive regulation of establishment of protein localization to telomere(GO:1904851) |
0.4 | 1.3 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.4 | 0.4 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.4 | 1.7 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.4 | 0.8 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.4 | 3.8 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.4 | 7.9 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.4 | 17.1 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.4 | 1.2 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.4 | 4.6 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.4 | 0.8 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.4 | 1.7 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.4 | 1.2 | GO:0030194 | positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
0.4 | 0.4 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.4 | 0.8 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.4 | 1.6 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.4 | 2.5 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.4 | 0.4 | GO:0015669 | gas transport(GO:0015669) |
0.4 | 1.2 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.4 | 4.1 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.4 | 0.4 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.4 | 0.8 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) |
0.4 | 1.6 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.4 | 0.4 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.4 | 2.9 | GO:0006968 | cellular defense response(GO:0006968) |
0.4 | 1.2 | GO:0070266 | necroptotic process(GO:0070266) |
0.4 | 2.0 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.4 | 0.4 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.4 | 3.6 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.4 | 1.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.4 | 0.8 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.4 | 4.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.4 | 2.4 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.4 | 0.4 | GO:0019627 | urea metabolic process(GO:0019627) |
0.4 | 0.8 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.4 | 1.2 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.4 | 0.4 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.4 | 2.4 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.4 | 0.8 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.4 | 2.8 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.4 | 2.0 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.4 | 0.4 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.4 | 1.6 | GO:0007144 | female meiosis I(GO:0007144) |
0.4 | 0.4 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.4 | 5.5 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.4 | 3.9 | GO:0070670 | response to interleukin-4(GO:0070670) cellular response to interleukin-4(GO:0071353) |
0.4 | 0.8 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.4 | 0.8 | GO:0006116 | NADH oxidation(GO:0006116) |
0.4 | 0.4 | GO:0072395 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.4 | 6.2 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.4 | 2.7 | GO:0048757 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.4 | 0.8 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.4 | 1.2 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.4 | 0.4 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.4 | 2.7 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.4 | 0.8 | GO:0009249 | protein lipoylation(GO:0009249) |
0.4 | 0.4 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.4 | 2.3 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.4 | 0.4 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.4 | 0.8 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.4 | 3.8 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.4 | 1.9 | GO:0042026 | protein refolding(GO:0042026) |
0.4 | 3.0 | GO:0046831 | regulation of nucleobase-containing compound transport(GO:0032239) regulation of RNA export from nucleus(GO:0046831) |
0.4 | 1.1 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.4 | 1.5 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.4 | 3.0 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.4 | 1.1 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.4 | 5.2 | GO:0006301 | postreplication repair(GO:0006301) |
0.4 | 0.7 | GO:0033574 | response to testosterone(GO:0033574) |
0.4 | 2.6 | GO:0071173 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
0.4 | 0.4 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.4 | 0.7 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.4 | 0.7 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.4 | 0.7 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.4 | 2.6 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.4 | 1.1 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.4 | 1.8 | GO:0016556 | mRNA modification(GO:0016556) |
0.4 | 1.5 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.4 | 0.7 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.4 | 0.7 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.4 | 2.2 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.4 | 0.7 | GO:0070555 | response to interleukin-1(GO:0070555) |
0.4 | 1.5 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.4 | 1.1 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.4 | 2.2 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.4 | 3.3 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.4 | 7.2 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.4 | 1.8 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.4 | 1.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.4 | 0.7 | GO:1903998 | regulation of eating behavior(GO:1903998) negative regulation of eating behavior(GO:1903999) |
0.4 | 0.4 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.4 | 3.2 | GO:0002381 | immunoglobulin production involved in immunoglobulin mediated immune response(GO:0002381) |
0.4 | 0.4 | GO:0033029 | regulation of neutrophil apoptotic process(GO:0033029) |
0.4 | 1.1 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.4 | 1.4 | GO:0016115 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.4 | 1.8 | GO:0051013 | microtubule severing(GO:0051013) |
0.4 | 0.4 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.4 | 3.9 | GO:0000154 | rRNA modification(GO:0000154) |
0.4 | 29.3 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.4 | 2.1 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.4 | 1.4 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.4 | 0.4 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.3 | 2.1 | GO:0051026 | chiasma assembly(GO:0051026) |
0.3 | 0.3 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.3 | 1.0 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.3 | 4.5 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.3 | 0.3 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.3 | 0.7 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.3 | 0.3 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.3 | 5.2 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.3 | 3.8 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.3 | 0.7 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.3 | 1.0 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.3 | 1.0 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.3 | 1.0 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) |
0.3 | 0.3 | GO:0007135 | meiosis II(GO:0007135) meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.3 | 0.7 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.3 | 9.1 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.3 | 1.0 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.3 | 2.7 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.3 | 1.3 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.3 | 4.7 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.3 | 0.7 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.3 | 0.3 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.3 | 1.0 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.3 | 0.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.3 | 2.0 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.3 | 2.3 | GO:0006560 | proline metabolic process(GO:0006560) |
0.3 | 1.0 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.3 | 1.0 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.3 | 0.7 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.3 | 0.3 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.3 | 0.7 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.3 | 0.3 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.3 | 0.7 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.3 | 1.0 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.3 | 0.7 | GO:0042525 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.3 | 1.6 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.3 | 1.0 | GO:0061515 | myeloid cell development(GO:0061515) |
0.3 | 1.6 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.3 | 2.3 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.3 | 1.0 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.3 | 0.3 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.3 | 0.3 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.3 | 1.3 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.3 | 3.9 | GO:0045214 | sarcomere organization(GO:0045214) |
0.3 | 1.0 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.3 | 0.6 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.3 | 7.4 | GO:0006284 | base-excision repair(GO:0006284) |
0.3 | 1.3 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.3 | 0.3 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
0.3 | 0.3 | GO:0032439 | endosome localization(GO:0032439) |
0.3 | 0.3 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.3 | 1.0 | GO:0090155 | regulation of sphingolipid biosynthetic process(GO:0090153) negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) regulation of membrane lipid metabolic process(GO:1905038) |
0.3 | 2.9 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.3 | 2.5 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.3 | 0.3 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.3 | 1.3 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.3 | 0.3 | GO:1904814 | regulation of protein localization to chromosome, telomeric region(GO:1904814) |
0.3 | 0.9 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.3 | 0.3 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.3 | 0.9 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.3 | 0.3 | GO:0042701 | progesterone secretion(GO:0042701) |
0.3 | 1.5 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.3 | 1.2 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.3 | 0.9 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.3 | 0.9 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.3 | 0.3 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.3 | 1.2 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.3 | 1.5 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.3 | 0.3 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.3 | 0.6 | GO:0030239 | myofibril assembly(GO:0030239) |
0.3 | 4.6 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.3 | 1.5 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.3 | 2.1 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) |
0.3 | 0.9 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.3 | 0.3 | GO:0060920 | cardiac pacemaker cell differentiation(GO:0060920) |
0.3 | 3.3 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.3 | 1.2 | GO:0045922 | negative regulation of fatty acid metabolic process(GO:0045922) |
0.3 | 0.9 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.3 | 0.3 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.3 | 0.6 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.3 | 1.2 | GO:0045821 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.3 | 1.8 | GO:0048525 | negative regulation of viral process(GO:0048525) |
0.3 | 0.6 | GO:0019042 | viral latency(GO:0019042) |
0.3 | 0.9 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.3 | 0.3 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.3 | 0.9 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.3 | 3.3 | GO:0043297 | apical junction assembly(GO:0043297) |
0.3 | 0.6 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.3 | 0.9 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
0.3 | 0.6 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.3 | 14.5 | GO:0007030 | Golgi organization(GO:0007030) |
0.3 | 0.9 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.3 | 2.7 | GO:0090224 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
0.3 | 1.8 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.3 | 0.3 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.3 | 0.3 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.3 | 0.6 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.3 | 0.6 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.3 | 2.0 | GO:0071356 | cellular response to tumor necrosis factor(GO:0071356) |
0.3 | 0.9 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.3 | 0.6 | GO:0070268 | cornification(GO:0070268) |
0.3 | 0.6 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.3 | 1.7 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.3 | 8.4 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.3 | 0.9 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.3 | 2.0 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.3 | 8.3 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.3 | 2.0 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.3 | 0.9 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.3 | 0.6 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.3 | 0.9 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.3 | 0.3 | GO:0007567 | parturition(GO:0007567) |
0.3 | 0.6 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.3 | 3.7 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.3 | 0.6 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) |
0.3 | 0.9 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.3 | 2.3 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.3 | 1.1 | GO:0031577 | spindle checkpoint(GO:0031577) |
0.3 | 0.3 | GO:0002418 | immune response to tumor cell(GO:0002418) |
0.3 | 3.7 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.3 | 1.4 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.3 | 0.8 | GO:0007000 | nucleolus organization(GO:0007000) |
0.3 | 1.1 | GO:0033750 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.3 | 0.6 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.3 | 6.9 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.3 | 0.3 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.3 | 4.7 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.3 | 0.5 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.3 | 1.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.3 | 1.9 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.3 | 9.5 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.3 | 0.3 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.3 | 3.5 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.3 | 0.8 | GO:0007525 | somatic muscle development(GO:0007525) |
0.3 | 0.3 | GO:0034204 | lipid translocation(GO:0034204) |
0.3 | 0.8 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.3 | 0.8 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.3 | 0.5 | GO:0036124 | histone H3-K9 trimethylation(GO:0036124) |
0.3 | 0.8 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.3 | 0.5 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.3 | 2.9 | GO:0045116 | protein neddylation(GO:0045116) |
0.3 | 0.3 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.3 | 1.3 | GO:0001945 | lymph vessel development(GO:0001945) |
0.3 | 2.4 | GO:0001675 | acrosome assembly(GO:0001675) |
0.3 | 0.8 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.3 | 0.3 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.3 | 5.0 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.3 | 1.6 | GO:0030575 | nuclear body organization(GO:0030575) |
0.3 | 0.3 | GO:0061724 | lipophagy(GO:0061724) |
0.3 | 0.3 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
0.3 | 0.8 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.3 | 0.3 | GO:0072350 | tricarboxylic acid metabolic process(GO:0072350) |
0.3 | 1.3 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.3 | 0.3 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.3 | 5.2 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.3 | 1.8 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.3 | 1.0 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.3 | 1.0 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.3 | 1.5 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.3 | 0.3 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.3 | 5.1 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.3 | 10.5 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.3 | 5.9 | GO:0030168 | platelet activation(GO:0030168) |
0.3 | 1.5 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.3 | 0.8 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.3 | 5.3 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.3 | 0.3 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.3 | 1.0 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.3 | 1.0 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.3 | 4.8 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.3 | 1.0 | GO:0060177 | regulation of angiotensin metabolic process(GO:0060177) |
0.3 | 1.8 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.3 | 0.5 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.2 | 4.0 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.2 | 1.7 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.2 | 0.2 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.2 | 1.2 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.2 | 4.2 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.2 | 0.7 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.2 | 0.2 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.2 | 0.2 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.2 | 0.2 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.2 | 0.2 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.2 | 1.0 | GO:0051697 | protein delipidation(GO:0051697) |
0.2 | 0.5 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.2 | 0.2 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.2 | 0.5 | GO:0051304 | chromosome separation(GO:0051304) |
0.2 | 0.5 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.2 | 2.6 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 0.5 | GO:0002254 | kinin cascade(GO:0002254) |
0.2 | 1.2 | GO:0034063 | stress granule assembly(GO:0034063) |
0.2 | 0.5 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.2 | 0.5 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.2 | 0.5 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process through glucose-1-phosphate(GO:0061622) glycolytic process from galactose(GO:0061623) |
0.2 | 19.9 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.2 | 0.2 | GO:2000406 | positive regulation of T cell migration(GO:2000406) |
0.2 | 0.2 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.2 | 0.9 | GO:0097421 | liver regeneration(GO:0097421) |
0.2 | 0.2 | GO:2000104 | replication fork protection(GO:0048478) negative regulation of DNA-dependent DNA replication(GO:2000104) |
0.2 | 0.2 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.2 | 0.2 | GO:1902591 | single-organism membrane budding(GO:1902591) |
0.2 | 0.2 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.2 | 0.5 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.2 | 1.1 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.2 | 2.9 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.2 | 1.3 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.2 | 0.2 | GO:0071634 | regulation of transforming growth factor beta production(GO:0071634) |
0.2 | 0.2 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.2 | 0.9 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.2 | 10.2 | GO:0051028 | mRNA transport(GO:0051028) |
0.2 | 0.4 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.2 | 5.1 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.2 | 0.2 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.2 | 0.4 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.2 | 0.4 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.2 | 0.7 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.2 | 0.4 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.2 | 0.2 | GO:0007619 | courtship behavior(GO:0007619) |
0.2 | 0.2 | GO:0051342 | protein maturation by protein folding(GO:0022417) regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.2 | 1.3 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 0.6 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.2 | 1.3 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.2 | 1.1 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.2 | 4.7 | GO:0006959 | humoral immune response(GO:0006959) |
0.2 | 7.6 | GO:0048002 | antigen processing and presentation of peptide antigen(GO:0048002) |
0.2 | 0.4 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.2 | 2.3 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.2 | 0.8 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.2 | 0.6 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.2 | 0.6 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.2 | 0.2 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.2 | 0.6 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.2 | 0.2 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.2 | 2.4 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.2 | 0.6 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.2 | 0.6 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.2 | 0.4 | GO:0046688 | response to copper ion(GO:0046688) |
0.2 | 3.0 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.2 | 0.8 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.2 | 0.2 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.2 | 1.6 | GO:0019682 | glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.2 | 0.2 | GO:0032647 | regulation of interferon-alpha production(GO:0032647) |
0.2 | 0.8 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.2 | 1.0 | GO:0001759 | organ induction(GO:0001759) |
0.2 | 2.6 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.2 | 0.4 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.2 | 4.5 | GO:0031424 | keratinization(GO:0031424) |
0.2 | 0.2 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.2 | 0.6 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.2 | 0.2 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.2 | 1.7 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.2 | 1.7 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.2 | 0.4 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.2 | 1.0 | GO:0060337 | type I interferon signaling pathway(GO:0060337) |
0.2 | 0.2 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.2 | 0.2 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.2 | 0.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.2 | 8.3 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.2 | 1.5 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.2 | 2.5 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.2 | 0.6 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.2 | 0.4 | GO:0015884 | folic acid transport(GO:0015884) |
0.2 | 0.4 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.2 | 0.2 | GO:0010692 | regulation of alkaline phosphatase activity(GO:0010692) |
0.2 | 0.4 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.2 | 0.4 | GO:0010225 | response to UV-C(GO:0010225) |
0.2 | 2.2 | GO:0060325 | face morphogenesis(GO:0060325) |
0.2 | 0.6 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.2 | 0.4 | GO:0033762 | response to glucagon(GO:0033762) |
0.2 | 0.6 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.2 | 2.4 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.2 | 0.6 | GO:0009309 | polyamine biosynthetic process(GO:0006596) amine biosynthetic process(GO:0009309) cellular biogenic amine biosynthetic process(GO:0042401) |
0.2 | 1.3 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.2 | 0.2 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.2 | 0.5 | GO:0002639 | positive regulation of immunoglobulin production(GO:0002639) |
0.2 | 0.4 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.2 | 0.2 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.2 | 0.4 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.2 | 0.2 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.2 | 0.7 | GO:0050832 | defense response to fungus(GO:0050832) |
0.2 | 0.7 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.2 | 1.4 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.2 | 0.9 | GO:0036474 | cell death in response to hydrogen peroxide(GO:0036474) |
0.2 | 0.2 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.2 | 0.9 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.2 | 0.2 | GO:0071025 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.2 | 0.2 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.2 | 1.6 | GO:0019915 | lipid storage(GO:0019915) |
0.2 | 0.5 | GO:0072678 | T cell migration(GO:0072678) |
0.2 | 0.2 | GO:0032252 | secretory granule localization(GO:0032252) |
0.2 | 4.4 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.2 | 0.5 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.2 | 1.2 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 1.0 | GO:0006465 | signal peptide processing(GO:0006465) |
0.2 | 0.8 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.2 | 0.2 | GO:0071295 | cellular response to vitamin(GO:0071295) |
0.2 | 0.2 | GO:0006595 | polyamine metabolic process(GO:0006595) |
0.2 | 0.3 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.2 | 1.5 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.2 | 1.0 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.2 | 0.6 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.2 | 3.6 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.2 | 0.6 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.2 | 1.1 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
0.2 | 0.5 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.2 | 1.1 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.2 | 0.6 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.2 | 1.4 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.2 | 0.3 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.2 | 0.5 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 0.3 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.2 | 1.8 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.2 | 0.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.2 | 0.3 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.2 | 0.6 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 0.3 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.2 | 0.5 | GO:0010165 | response to X-ray(GO:0010165) |
0.2 | 1.2 | GO:0016926 | protein desumoylation(GO:0016926) |
0.2 | 0.6 | GO:0031297 | replication fork processing(GO:0031297) |
0.2 | 0.6 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.1 | 2.1 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 2.4 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 0.4 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.1 | 2.8 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.1 | 0.3 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 0.9 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.3 | GO:0060525 | prostate glandular acinus development(GO:0060525) |
0.1 | 1.3 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 0.9 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.1 | 1.2 | GO:0006081 | cellular aldehyde metabolic process(GO:0006081) |
0.1 | 0.3 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.4 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.1 | 0.6 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.6 | GO:0032392 | DNA geometric change(GO:0032392) |
0.1 | 0.4 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 4.2 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 0.6 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.1 | 0.1 | GO:0001768 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.1 | 1.0 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.4 | GO:0090151 | protein import into mitochondrial inner membrane(GO:0045039) establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.1 | 0.1 | GO:0071107 | response to parathyroid hormone(GO:0071107) |
0.1 | 1.0 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.1 | 0.4 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.1 | 0.3 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.1 | 1.0 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 0.7 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.1 | 13.6 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.1 | 1.6 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.1 | 1.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.1 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.1 | 0.5 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 0.1 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 0.7 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.5 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 0.7 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.1 | 0.1 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.1 | 1.6 | GO:0070206 | protein trimerization(GO:0070206) |
0.1 | 0.4 | GO:0001909 | leukocyte mediated cytotoxicity(GO:0001909) |
0.1 | 0.1 | GO:0002667 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.1 | 0.5 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.1 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.1 | 8.2 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.1 | 0.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 1.5 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 0.1 | GO:2000316 | regulation of T-helper 17 type immune response(GO:2000316) |
0.1 | 1.7 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.1 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.1 | 0.1 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.1 | 0.2 | GO:0009624 | response to nematode(GO:0009624) |
0.1 | 4.0 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.1 | 1.3 | GO:0071466 | cellular response to xenobiotic stimulus(GO:0071466) |
0.1 | 0.2 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
0.1 | 1.1 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 1.2 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.3 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.1 | 0.3 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 0.6 | GO:0070633 | transepithelial transport(GO:0070633) |
0.1 | 0.2 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.1 | 0.2 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 0.6 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.4 | GO:0007143 | female meiotic division(GO:0007143) |
0.1 | 0.1 | GO:0051409 | response to nitrosative stress(GO:0051409) cellular response to nitrosative stress(GO:0071500) |
0.1 | 0.3 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.1 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.1 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 0.1 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.1 | 0.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.1 | 0.2 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.1 | 1.8 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.1 | 0.2 | GO:0043921 | modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
0.1 | 0.3 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.1 | 0.2 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.2 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 8.3 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.1 | 0.4 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.2 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.4 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.1 | 0.5 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 0.6 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.1 | 0.1 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.1 | 1.6 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.1 | 0.1 | GO:0050856 | regulation of T cell receptor signaling pathway(GO:0050856) |
0.1 | 15.7 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 0.1 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.6 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 1.5 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 0.2 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.2 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.7 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.1 | 0.1 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.1 | 0.8 | GO:0070303 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.1 | 0.1 | GO:0006266 | DNA ligation(GO:0006266) |
0.1 | 0.5 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.2 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.1 | 0.3 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.2 | GO:0046909 | intermembrane transport(GO:0046909) |
0.1 | 0.5 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.1 | 0.1 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.1 | 0.1 | GO:0032205 | negative regulation of telomere maintenance(GO:0032205) negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
0.1 | 5.6 | GO:0051607 | defense response to virus(GO:0051607) |
0.1 | 1.1 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.1 | 0.2 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.6 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 0.2 | GO:1903393 | positive regulation of adherens junction organization(GO:1903393) |
0.1 | 1.6 | GO:0009060 | aerobic respiration(GO:0009060) |
0.1 | 0.2 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
0.1 | 0.1 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.2 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.1 | 0.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 0.2 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.1 | 0.3 | GO:0016101 | diterpenoid metabolic process(GO:0016101) |
0.1 | 0.3 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.1 | 0.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.4 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.1 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.1 | 0.1 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.1 | 0.1 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.1 | 0.2 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 6.0 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.2 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 0.2 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.1 | 0.1 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.1 | 0.1 | GO:0006063 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) cellular glucuronidation(GO:0052695) |
0.1 | 0.4 | GO:0051180 | vitamin transport(GO:0051180) |
0.1 | 1.7 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.2 | GO:0032196 | transposition(GO:0032196) |
0.1 | 0.1 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.1 | 0.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 0.0 | GO:0060142 | regulation of syncytium formation by plasma membrane fusion(GO:0060142) |
0.0 | 0.2 | GO:0050892 | intestinal absorption(GO:0050892) |
0.0 | 0.1 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.0 | 0.0 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 0.0 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.0 | 0.1 | GO:0072525 | pyridine-containing compound biosynthetic process(GO:0072525) |
0.0 | 0.0 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.0 | 0.1 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.0 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 0.1 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.0 | 0.1 | GO:0003159 | morphogenesis of an endothelium(GO:0003159) |
0.0 | 0.1 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.0 | 0.0 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.0 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.0 | 0.1 | GO:0042107 | cytokine metabolic process(GO:0042107) |
0.0 | 0.0 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.0 | 0.1 | GO:0051702 | interaction with symbiont(GO:0051702) |
0.0 | 0.0 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.0 | 0.2 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.0 | 0.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.1 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 1.5 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.0 | 0.1 | GO:0042628 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.0 | 0.1 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
0.0 | 0.0 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.0 | 0.0 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.0 | 0.0 | GO:0051132 | NK T cell activation(GO:0051132) |
0.0 | 0.3 | GO:0010906 | regulation of glucose metabolic process(GO:0010906) |
0.0 | 0.0 | GO:0072599 | establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.0 | 0.0 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.0 | 0.0 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.0 | 0.0 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.0 | 0.0 | GO:1900135 | positive regulation of renin secretion into blood stream(GO:1900135) |
0.0 | 0.1 | GO:0080111 | DNA demethylation(GO:0080111) |
0.0 | 0.0 | GO:0042182 | ketone catabolic process(GO:0042182) |
0.0 | 0.0 | GO:0006760 | folic acid-containing compound metabolic process(GO:0006760) |
0.0 | 0.0 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.0 | 0.0 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.0 | 0.1 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.0 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.0 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.0 | 0.0 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.0 | 0.0 | GO:1903209 | positive regulation of oxidative stress-induced cell death(GO:1903209) |
0.0 | 0.0 | GO:0032689 | negative regulation of interferon-gamma production(GO:0032689) |
0.0 | 0.0 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.0 | 0.1 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.0 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.0 | 0.0 | GO:0009219 | pyrimidine deoxyribonucleotide metabolic process(GO:0009219) |
0.0 | 0.1 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.0 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.9 | 41.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
5.4 | 26.8 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
3.6 | 14.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
3.2 | 16.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
2.7 | 8.1 | GO:0032127 | dense core granule membrane(GO:0032127) |
2.6 | 10.5 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
2.5 | 7.6 | GO:0005833 | hemoglobin complex(GO:0005833) |
2.5 | 14.9 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
2.4 | 7.3 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
2.4 | 7.3 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
2.3 | 6.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
2.2 | 6.7 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
2.1 | 14.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
2.1 | 10.4 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
2.0 | 8.2 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
2.0 | 12.1 | GO:0042629 | mast cell granule(GO:0042629) |
2.0 | 20.0 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
2.0 | 10.0 | GO:0033093 | Weibel-Palade body(GO:0033093) |
1.9 | 15.6 | GO:0030056 | hemidesmosome(GO:0030056) |
1.8 | 10.6 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
1.7 | 13.6 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
1.7 | 5.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.6 | 23.0 | GO:0031528 | microvillus membrane(GO:0031528) |
1.6 | 1.6 | GO:0070552 | BRISC complex(GO:0070552) |
1.6 | 3.1 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
1.5 | 19.9 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
1.5 | 36.6 | GO:0097228 | sperm principal piece(GO:0097228) |
1.5 | 6.0 | GO:1990130 | Iml1 complex(GO:1990130) |
1.5 | 7.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.4 | 5.7 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
1.4 | 7.1 | GO:0097422 | tubular endosome(GO:0097422) |
1.4 | 4.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
1.4 | 8.5 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.4 | 5.6 | GO:0005642 | annulate lamellae(GO:0005642) |
1.4 | 5.6 | GO:0031094 | platelet dense tubular network(GO:0031094) |
1.4 | 5.6 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
1.4 | 5.5 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
1.4 | 4.1 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
1.4 | 4.1 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
1.4 | 19.0 | GO:0001891 | phagocytic cup(GO:0001891) |
1.3 | 5.4 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
1.3 | 10.7 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
1.3 | 21.2 | GO:0000145 | exocyst(GO:0000145) |
1.3 | 1.3 | GO:0071438 | invadopodium membrane(GO:0071438) |
1.3 | 1.3 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
1.3 | 7.7 | GO:0090543 | Flemming body(GO:0090543) |
1.3 | 14.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
1.3 | 5.1 | GO:0042583 | chromaffin granule(GO:0042583) |
1.3 | 8.8 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.3 | 5.0 | GO:0097524 | sperm plasma membrane(GO:0097524) |
1.2 | 9.8 | GO:0005861 | troponin complex(GO:0005861) |
1.2 | 14.6 | GO:0042581 | specific granule(GO:0042581) |
1.2 | 27.9 | GO:0008305 | integrin complex(GO:0008305) |
1.2 | 3.6 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
1.2 | 3.5 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
1.2 | 5.9 | GO:0005638 | lamin filament(GO:0005638) |
1.1 | 5.5 | GO:0043202 | lysosomal lumen(GO:0043202) |
1.1 | 2.2 | GO:0005579 | membrane attack complex(GO:0005579) |
1.1 | 8.7 | GO:0001650 | fibrillar center(GO:0001650) |
1.1 | 5.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.1 | 4.3 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
1.0 | 4.2 | GO:0031298 | replication fork protection complex(GO:0031298) |
1.0 | 4.2 | GO:0097452 | GAIT complex(GO:0097452) |
1.0 | 10.4 | GO:0097539 | ciliary transition fiber(GO:0097539) |
1.0 | 4.1 | GO:0019815 | B cell receptor complex(GO:0019815) |
1.0 | 4.1 | GO:0097450 | astrocyte end-foot(GO:0097450) |
1.0 | 5.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
1.0 | 4.0 | GO:0000805 | X chromosome(GO:0000805) |
1.0 | 3.0 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
1.0 | 4.0 | GO:0042627 | chylomicron(GO:0042627) |
1.0 | 1.0 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
1.0 | 15.8 | GO:0000421 | autophagosome membrane(GO:0000421) |
1.0 | 3.9 | GO:0045293 | mRNA editing complex(GO:0045293) |
1.0 | 2.0 | GO:0001651 | dense fibrillar component(GO:0001651) |
1.0 | 1.9 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
1.0 | 2.9 | GO:0005879 | axonemal microtubule(GO:0005879) |
1.0 | 14.4 | GO:0005865 | striated muscle thin filament(GO:0005865) |
1.0 | 4.8 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
1.0 | 2.9 | GO:0097413 | Lewy body(GO:0097413) |
0.9 | 3.8 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.9 | 4.7 | GO:0002102 | podosome(GO:0002102) |
0.9 | 3.8 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.9 | 0.9 | GO:0089701 | U2AF(GO:0089701) |
0.9 | 4.7 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.9 | 81.7 | GO:0072562 | blood microparticle(GO:0072562) |
0.9 | 23.4 | GO:0001772 | immunological synapse(GO:0001772) |
0.9 | 4.7 | GO:0045179 | apical cortex(GO:0045179) |
0.9 | 6.5 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.9 | 9.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.9 | 3.7 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.9 | 8.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.9 | 0.9 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.9 | 3.7 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.9 | 2.7 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.9 | 9.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.9 | 1.8 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.9 | 11.5 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.9 | 13.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.9 | 1.8 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.9 | 4.4 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.9 | 0.9 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.9 | 8.6 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.9 | 7.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.9 | 6.8 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.8 | 2.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.8 | 1.7 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.8 | 1.7 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.8 | 26.1 | GO:0015030 | Cajal body(GO:0015030) |
0.8 | 8.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.8 | 50.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.8 | 6.7 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.8 | 3.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.8 | 7.5 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.8 | 2.5 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.8 | 5.0 | GO:0000796 | condensin complex(GO:0000796) |
0.8 | 4.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.8 | 8.2 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.8 | 2.4 | GO:0045180 | basal cortex(GO:0045180) |
0.8 | 1.6 | GO:0035861 | site of double-strand break(GO:0035861) |
0.8 | 1.6 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.8 | 4.8 | GO:0031415 | NatA complex(GO:0031415) |
0.8 | 3.2 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.8 | 3.2 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.8 | 4.0 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.8 | 3.2 | GO:0070938 | contractile ring(GO:0070938) |
0.8 | 23.6 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.8 | 1.6 | GO:0005915 | zonula adherens(GO:0005915) |
0.8 | 3.1 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.8 | 6.1 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.8 | 9.1 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.8 | 3.8 | GO:0016589 | NURF complex(GO:0016589) |
0.8 | 2.3 | GO:1990923 | PET complex(GO:1990923) |
0.7 | 6.7 | GO:0032426 | stereocilium tip(GO:0032426) |
0.7 | 29.7 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.7 | 6.6 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.7 | 5.9 | GO:0005916 | fascia adherens(GO:0005916) |
0.7 | 1.4 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.7 | 3.6 | GO:0031983 | vesicle lumen(GO:0031983) |
0.7 | 2.9 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.7 | 4.3 | GO:0071986 | Ragulator complex(GO:0071986) |
0.7 | 23.4 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.7 | 2.8 | GO:0033269 | internode region of axon(GO:0033269) |
0.7 | 11.9 | GO:0045120 | pronucleus(GO:0045120) |
0.7 | 14.6 | GO:0042588 | zymogen granule(GO:0042588) |
0.7 | 2.1 | GO:0097427 | microtubule bundle(GO:0097427) |
0.7 | 2.1 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.7 | 1.4 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.7 | 2.7 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.7 | 9.5 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.7 | 4.8 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.7 | 6.1 | GO:0000974 | Prp19 complex(GO:0000974) |
0.7 | 2.0 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.7 | 68.8 | GO:0000793 | condensed chromosome(GO:0000793) |
0.7 | 1.3 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.7 | 9.2 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.6 | 2.6 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.6 | 0.6 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.6 | 3.8 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.6 | 0.6 | GO:1990423 | RZZ complex(GO:1990423) |
0.6 | 44.5 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.6 | 3.7 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.6 | 26.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.6 | 4.3 | GO:0031931 | TORC1 complex(GO:0031931) |
0.6 | 39.5 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.6 | 1.2 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.6 | 4.9 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.6 | 1.2 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.6 | 3.0 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.6 | 3.0 | GO:0016600 | flotillin complex(GO:0016600) |
0.6 | 1.2 | GO:0005914 | spot adherens junction(GO:0005914) |
0.6 | 2.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.6 | 2.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.6 | 0.6 | GO:0032010 | phagolysosome(GO:0032010) |
0.6 | 4.6 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.6 | 2.3 | GO:0005827 | polar microtubule(GO:0005827) |
0.6 | 6.8 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.6 | 24.0 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.6 | 2.2 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.5 | 1.6 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.5 | 4.4 | GO:0070652 | HAUS complex(GO:0070652) |
0.5 | 3.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.5 | 0.5 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.5 | 1.6 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.5 | 1.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.5 | 1.6 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.5 | 28.2 | GO:0016363 | nuclear matrix(GO:0016363) |
0.5 | 3.7 | GO:0042382 | paraspeckles(GO:0042382) |
0.5 | 18.4 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.5 | 1.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.5 | 1.6 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.5 | 2.1 | GO:1990246 | uniplex complex(GO:1990246) |
0.5 | 2.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.5 | 3.1 | GO:0031902 | late endosome membrane(GO:0031902) |
0.5 | 25.7 | GO:0005811 | lipid particle(GO:0005811) |
0.5 | 4.1 | GO:0005682 | U5 snRNP(GO:0005682) |
0.5 | 2.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.5 | 1.0 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.5 | 16.2 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.5 | 11.1 | GO:0034451 | centriolar satellite(GO:0034451) |
0.5 | 5.0 | GO:0032039 | integrator complex(GO:0032039) |
0.5 | 21.5 | GO:0005795 | Golgi stack(GO:0005795) |
0.5 | 1.0 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.5 | 4.5 | GO:0097542 | ciliary tip(GO:0097542) |
0.5 | 1.5 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.5 | 2.0 | GO:0070876 | SOSS complex(GO:0070876) |
0.5 | 3.9 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.5 | 13.1 | GO:0016592 | mediator complex(GO:0016592) |
0.5 | 1.4 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.5 | 9.1 | GO:0005876 | spindle microtubule(GO:0005876) |
0.5 | 1.4 | GO:0000346 | transcription export complex(GO:0000346) |
0.5 | 1.9 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.5 | 1.4 | GO:0097342 | ripoptosome(GO:0097342) |
0.5 | 37.3 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.5 | 17.9 | GO:0005643 | nuclear pore(GO:0005643) |
0.5 | 7.5 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.5 | 6.5 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.5 | 1.4 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.5 | 97.8 | GO:0005925 | cell-substrate adherens junction(GO:0005924) focal adhesion(GO:0005925) |
0.5 | 0.5 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.5 | 2.7 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.5 | 8.1 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.5 | 1.8 | GO:0044448 | cell cortex part(GO:0044448) |
0.4 | 0.9 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.4 | 1.3 | GO:0042555 | MCM complex(GO:0042555) |
0.4 | 2.2 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.4 | 6.1 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.4 | 30.0 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.4 | 6.5 | GO:0071010 | prespliceosome(GO:0071010) |
0.4 | 21.9 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.4 | 4.3 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.4 | 1.3 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.4 | 3.4 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.4 | 3.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.4 | 1.7 | GO:0071564 | npBAF complex(GO:0071564) |
0.4 | 8.0 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.4 | 1.2 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.4 | 17.9 | GO:0016459 | myosin complex(GO:0016459) |
0.4 | 0.4 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.4 | 1.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.4 | 2.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.4 | 1.2 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.4 | 127.1 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.4 | 1.1 | GO:0072487 | MSL complex(GO:0072487) |
0.4 | 1.5 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.4 | 0.7 | GO:0072687 | meiotic spindle(GO:0072687) |
0.4 | 1.1 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.4 | 21.9 | GO:0005581 | collagen trimer(GO:0005581) |
0.4 | 0.7 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.4 | 5.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.4 | 0.7 | GO:0005955 | calcineurin complex(GO:0005955) |
0.4 | 0.7 | GO:0097255 | R2TP complex(GO:0097255) |
0.4 | 0.7 | GO:0098536 | deuterosome(GO:0098536) |
0.4 | 3.2 | GO:0031519 | PcG protein complex(GO:0031519) |
0.4 | 3.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.3 | 1.0 | GO:0048179 | activin receptor complex(GO:0048179) |
0.3 | 7.0 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.3 | 1.0 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.3 | 1.7 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.3 | 2.1 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.3 | 3.7 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.3 | 3.4 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.3 | 0.7 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.3 | 0.3 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.3 | 1.3 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.3 | 4.3 | GO:0005771 | multivesicular body(GO:0005771) |
0.3 | 0.3 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.3 | 1.6 | GO:0034719 | SMN complex(GO:0032797) SMN-Sm protein complex(GO:0034719) |
0.3 | 30.7 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.3 | 3.3 | GO:0005776 | autophagosome(GO:0005776) |
0.3 | 5.5 | GO:0042641 | actomyosin(GO:0042641) |
0.3 | 0.3 | GO:0042611 | MHC protein complex(GO:0042611) |
0.3 | 13.9 | GO:0001726 | ruffle(GO:0001726) |
0.3 | 0.6 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
0.3 | 0.6 | GO:0036452 | ESCRT complex(GO:0036452) |
0.3 | 11.5 | GO:0016605 | PML body(GO:0016605) |
0.3 | 0.9 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.3 | 3.1 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.3 | 0.3 | GO:0000322 | storage vacuole(GO:0000322) |
0.3 | 0.3 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.3 | 0.6 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.3 | 1.2 | GO:0000242 | pericentriolar material(GO:0000242) |
0.3 | 4.9 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.3 | 2.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 3.9 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.3 | 0.6 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.3 | 0.3 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.3 | 0.3 | GO:0043293 | apoptosome(GO:0043293) |
0.3 | 2.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.3 | 19.9 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.3 | 1.4 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.3 | 9.8 | GO:0030118 | clathrin coat(GO:0030118) |
0.3 | 1.4 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.3 | 3.1 | GO:0000786 | nucleosome(GO:0000786) |
0.3 | 1.7 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.3 | 0.3 | GO:0000811 | GINS complex(GO:0000811) |
0.3 | 1.6 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.3 | 1.6 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.3 | 0.8 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.3 | 0.8 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.3 | 4.1 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.3 | 0.8 | GO:0005796 | Golgi lumen(GO:0005796) |
0.3 | 1.1 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.3 | 0.3 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.3 | 1.1 | GO:0097225 | sperm midpiece(GO:0097225) |
0.3 | 7.5 | GO:0045171 | intercellular bridge(GO:0045171) |
0.3 | 15.0 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.3 | 442.0 | GO:0070062 | extracellular exosome(GO:0070062) |
0.3 | 0.8 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.3 | 24.6 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.3 | 0.3 | GO:0016234 | inclusion body(GO:0016234) |
0.3 | 39.8 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.3 | 14.4 | GO:0000502 | proteasome complex(GO:0000502) |
0.3 | 11.8 | GO:0016607 | nuclear speck(GO:0016607) |
0.3 | 0.3 | GO:0000812 | Swr1 complex(GO:0000812) |
0.3 | 0.3 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.3 | 1.0 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.3 | 8.3 | GO:0005604 | basement membrane(GO:0005604) |
0.3 | 1.0 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.2 | 12.6 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.2 | 0.7 | GO:0098687 | chromosomal region(GO:0098687) |
0.2 | 0.9 | GO:0035339 | SPOTS complex(GO:0035339) |
0.2 | 8.2 | GO:0000922 | spindle pole(GO:0000922) |
0.2 | 0.2 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.2 | 3.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.2 | 0.5 | GO:0042827 | platelet dense granule(GO:0042827) |
0.2 | 2.7 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.2 | 1.7 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 0.2 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.2 | 25.9 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.2 | 0.6 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 21.9 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.2 | 2.7 | GO:0016235 | aggresome(GO:0016235) |
0.2 | 4.4 | GO:0005819 | spindle(GO:0005819) |
0.2 | 2.0 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 1.0 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.2 | 0.4 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.2 | 0.4 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.2 | 1.0 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 0.6 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.2 | 167.4 | GO:0005654 | nucleoplasm(GO:0005654) |
0.2 | 0.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.2 | 0.2 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 1.0 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.2 | 1.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 0.3 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 5.0 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.4 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 10.1 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 0.4 | GO:0038201 | TORC2 complex(GO:0031932) TOR complex(GO:0038201) |
0.1 | 0.7 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.3 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 70.4 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.6 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.3 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.1 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.1 | 9.8 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.8 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.7 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.2 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 0.3 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 19.2 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 0.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.9 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 0.4 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.1 | GO:0042585 | germinal vesicle(GO:0042585) |
0.1 | 0.1 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 0.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.2 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.0 | 1.7 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.1 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.1 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 0.2 | GO:0032155 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.0 | 0.0 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 2.6 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.5 | 33.8 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
6.4 | 25.8 | GO:0031720 | haptoglobin binding(GO:0031720) |
6.1 | 18.2 | GO:0030620 | U2 snRNA binding(GO:0030620) |
5.5 | 22.1 | GO:0015265 | urea channel activity(GO:0015265) |
5.5 | 16.4 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
4.7 | 18.7 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
4.5 | 17.8 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
4.4 | 13.3 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
4.1 | 20.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
3.8 | 11.5 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
3.6 | 25.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
3.4 | 13.7 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
3.2 | 9.7 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
3.2 | 9.6 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
3.0 | 3.0 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
2.9 | 5.9 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
2.9 | 8.7 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
2.9 | 20.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
2.9 | 8.6 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
2.8 | 8.5 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
2.8 | 11.2 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
2.7 | 8.1 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
2.7 | 8.0 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
2.6 | 10.3 | GO:0051434 | BH3 domain binding(GO:0051434) |
2.4 | 4.9 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
2.4 | 7.3 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
2.4 | 7.3 | GO:0009041 | uridylate kinase activity(GO:0009041) |
2.4 | 12.2 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
2.4 | 7.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
2.2 | 6.7 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
2.2 | 8.9 | GO:0030284 | estrogen receptor activity(GO:0030284) |
2.2 | 4.4 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
2.2 | 6.6 | GO:0070644 | vitamin D response element binding(GO:0070644) |
2.1 | 6.4 | GO:0004064 | arylesterase activity(GO:0004064) |
2.1 | 12.8 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
2.1 | 12.7 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
2.1 | 6.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
2.1 | 14.8 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
2.0 | 4.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
2.0 | 2.0 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
2.0 | 8.0 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
2.0 | 8.0 | GO:0015057 | thrombin receptor activity(GO:0015057) |
2.0 | 11.9 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
2.0 | 5.9 | GO:0019770 | IgG receptor activity(GO:0019770) |
2.0 | 5.9 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
1.9 | 5.8 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
1.9 | 17.4 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
1.9 | 11.5 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
1.9 | 5.7 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
1.9 | 7.5 | GO:0015232 | heme transporter activity(GO:0015232) |
1.9 | 7.4 | GO:0051425 | PTB domain binding(GO:0051425) |
1.8 | 9.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
1.8 | 11.0 | GO:0004630 | phospholipase D activity(GO:0004630) |
1.8 | 7.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
1.8 | 5.5 | GO:0048030 | disaccharide binding(GO:0048030) |
1.8 | 7.3 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
1.8 | 10.9 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
1.8 | 10.9 | GO:0001727 | lipid kinase activity(GO:0001727) |
1.8 | 5.4 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
1.8 | 5.3 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
1.8 | 5.3 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
1.8 | 15.8 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
1.7 | 14.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
1.7 | 5.2 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
1.7 | 15.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.7 | 10.4 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
1.7 | 3.4 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
1.7 | 8.5 | GO:0042015 | interleukin-20 binding(GO:0042015) |
1.7 | 1.7 | GO:0016418 | S-acetyltransferase activity(GO:0016418) dihydrolipoamide S-acyltransferase activity(GO:0030523) |
1.7 | 22.0 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
1.7 | 5.0 | GO:0019862 | IgA binding(GO:0019862) |
1.7 | 6.7 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
1.6 | 6.6 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
1.6 | 6.4 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
1.6 | 3.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
1.6 | 9.6 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
1.6 | 9.6 | GO:0030274 | LIM domain binding(GO:0030274) |
1.6 | 4.8 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
1.6 | 6.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.6 | 6.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
1.6 | 6.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
1.6 | 3.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
1.6 | 6.2 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
1.5 | 6.2 | GO:0042731 | PH domain binding(GO:0042731) |
1.5 | 10.6 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
1.5 | 4.5 | GO:0030350 | iron-responsive element binding(GO:0030350) |
1.5 | 5.9 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
1.5 | 7.4 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
1.5 | 10.3 | GO:0016803 | ether hydrolase activity(GO:0016803) |
1.5 | 2.9 | GO:0050897 | cobalt ion binding(GO:0050897) |
1.5 | 10.2 | GO:0019957 | C-C chemokine binding(GO:0019957) |
1.4 | 1.4 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
1.4 | 21.5 | GO:0005521 | lamin binding(GO:0005521) |
1.4 | 4.3 | GO:1990239 | steroid hormone binding(GO:1990239) |
1.4 | 5.7 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
1.4 | 4.2 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
1.4 | 2.8 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
1.4 | 11.3 | GO:0003993 | acid phosphatase activity(GO:0003993) |
1.4 | 5.5 | GO:0009374 | biotin binding(GO:0009374) |
1.4 | 26.2 | GO:0030506 | ankyrin binding(GO:0030506) |
1.4 | 49.4 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
1.4 | 5.5 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
1.4 | 6.8 | GO:0052723 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
1.4 | 4.1 | GO:0031014 | troponin T binding(GO:0031014) |
1.4 | 4.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
1.3 | 2.7 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
1.3 | 5.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
1.3 | 5.3 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
1.3 | 3.9 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
1.3 | 14.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
1.3 | 1.3 | GO:0003896 | DNA primase activity(GO:0003896) |
1.3 | 3.9 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
1.3 | 2.6 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
1.3 | 5.1 | GO:0031433 | telethonin binding(GO:0031433) |
1.3 | 8.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
1.3 | 6.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
1.3 | 5.0 | GO:0002060 | purine nucleobase binding(GO:0002060) |
1.3 | 2.5 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
1.2 | 5.0 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
1.2 | 3.7 | GO:0008142 | oxysterol binding(GO:0008142) |
1.2 | 2.5 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
1.2 | 22.1 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
1.2 | 3.7 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.2 | 9.8 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
1.2 | 3.7 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
1.2 | 35.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
1.2 | 3.6 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
1.2 | 3.6 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
1.2 | 20.4 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
1.2 | 2.4 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
1.2 | 21.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
1.2 | 1.2 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
1.2 | 7.1 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
1.2 | 2.4 | GO:0070492 | oligosaccharide binding(GO:0070492) |
1.2 | 3.5 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
1.2 | 3.5 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.2 | 3.5 | GO:0030172 | troponin C binding(GO:0030172) |
1.2 | 4.7 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
1.2 | 32.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
1.2 | 3.5 | GO:0035174 | histone serine kinase activity(GO:0035174) |
1.1 | 3.4 | GO:0034618 | arginine binding(GO:0034618) |
1.1 | 3.4 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
1.1 | 3.4 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.1 | 2.3 | GO:0019959 | interleukin-8 binding(GO:0019959) |
1.1 | 4.5 | GO:0035473 | lipase binding(GO:0035473) |
1.1 | 1.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
1.1 | 4.4 | GO:0032052 | bile acid binding(GO:0032052) |
1.1 | 2.2 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
1.1 | 6.5 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
1.1 | 8.6 | GO:0043915 | cobinamide kinase activity(GO:0008819) phytol kinase activity(GO:0010276) phenol kinase activity(GO:0018720) cyclin-dependent protein kinase activating kinase regulator activity(GO:0019914) inositol tetrakisphosphate 2-kinase activity(GO:0032942) heptose 7-phosphate kinase activity(GO:0033785) aminoglycoside phosphotransferase activity(GO:0034071) eukaryotic elongation factor-2 kinase regulator activity(GO:0042556) eukaryotic elongation factor-2 kinase activator activity(GO:0042557) LPPG:FO 2-phospho-L-lactate transferase activity(GO:0043743) cytidine kinase activity(GO:0043771) glycerate 2-kinase activity(GO:0043798) (S)-lactate 2-kinase activity(GO:0043841) phosphoserine:homoserine phosphotransferase activity(GO:0043899) L-seryl-tRNA(Sec) kinase activity(GO:0043915) phosphocholine transferase activity(GO:0044605) GTP-dependent polynucleotide kinase activity(GO:0051735) farnesol kinase activity(GO:0052668) CTP:2-trans,-6-trans-farnesol kinase activity(GO:0052669) geraniol kinase activity(GO:0052670) geranylgeraniol kinase activity(GO:0052671) CTP:geranylgeraniol kinase activity(GO:0052672) prenol kinase activity(GO:0052673) 1-phosphatidylinositol-5-kinase activity(GO:0052810) 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
1.1 | 4.3 | GO:0043559 | insulin binding(GO:0043559) |
1.1 | 10.7 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
1.1 | 4.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
1.1 | 5.4 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
1.1 | 4.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
1.1 | 3.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.1 | 15.0 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
1.1 | 22.4 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
1.1 | 6.4 | GO:0005536 | glucose binding(GO:0005536) |
1.1 | 4.2 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
1.0 | 5.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
1.0 | 8.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
1.0 | 5.2 | GO:0008199 | ferric iron binding(GO:0008199) |
1.0 | 9.4 | GO:0031996 | thioesterase binding(GO:0031996) |
1.0 | 3.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
1.0 | 5.2 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
1.0 | 3.1 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
1.0 | 5.2 | GO:0016936 | galactoside binding(GO:0016936) |
1.0 | 4.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
1.0 | 3.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
1.0 | 5.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
1.0 | 3.1 | GO:0004104 | cholinesterase activity(GO:0004104) |
1.0 | 3.1 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
1.0 | 2.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
1.0 | 5.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
1.0 | 1.0 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
1.0 | 11.1 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
1.0 | 16.2 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
1.0 | 2.0 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
1.0 | 4.0 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
1.0 | 1.0 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
1.0 | 6.9 | GO:0051400 | BH domain binding(GO:0051400) |
1.0 | 1.9 | GO:0035877 | death effector domain binding(GO:0035877) |
1.0 | 32.1 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
1.0 | 2.9 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
1.0 | 27.2 | GO:0043531 | ADP binding(GO:0043531) |
1.0 | 2.9 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
1.0 | 4.8 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.9 | 0.9 | GO:0045340 | mercury ion binding(GO:0045340) |
0.9 | 5.6 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.9 | 0.9 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.9 | 0.9 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.9 | 6.5 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.9 | 1.9 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.9 | 2.8 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.9 | 2.8 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.9 | 7.3 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.9 | 2.7 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.9 | 6.4 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.9 | 0.9 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.9 | 0.9 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.9 | 11.8 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.9 | 2.7 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.9 | 7.3 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.9 | 9.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.9 | 1.8 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.9 | 8.1 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.9 | 6.3 | GO:0033691 | sialic acid binding(GO:0033691) |
0.9 | 3.6 | GO:0032564 | dATP binding(GO:0032564) |
0.9 | 1.8 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.9 | 2.7 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.9 | 12.5 | GO:0008143 | poly(A) binding(GO:0008143) |
0.9 | 2.7 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.9 | 9.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.9 | 2.6 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.9 | 7.0 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.9 | 2.6 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.9 | 3.5 | GO:0030984 | kininogen binding(GO:0030984) |
0.9 | 0.9 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.9 | 4.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.9 | 4.3 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.9 | 2.6 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.8 | 5.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.8 | 8.5 | GO:0005123 | death receptor binding(GO:0005123) |
0.8 | 5.9 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.8 | 2.5 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.8 | 3.4 | GO:0038132 | neuregulin binding(GO:0038132) |
0.8 | 16.8 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.8 | 2.5 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.8 | 4.2 | GO:0070061 | fructose binding(GO:0070061) |
0.8 | 13.4 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.8 | 0.8 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.8 | 4.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.8 | 17.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.8 | 4.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.8 | 4.1 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.8 | 4.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.8 | 9.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.8 | 2.5 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.8 | 4.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.8 | 11.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.8 | 3.3 | GO:0052717 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.8 | 0.8 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.8 | 2.4 | GO:0050692 | DBD domain binding(GO:0050692) |
0.8 | 6.4 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.8 | 0.8 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.8 | 2.4 | GO:0051734 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.8 | 3.2 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.8 | 1.6 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.8 | 4.8 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.8 | 3.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.8 | 0.8 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.8 | 2.4 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.8 | 3.9 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.8 | 2.4 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.8 | 3.1 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.8 | 3.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.8 | 2.3 | GO:2001070 | starch binding(GO:2001070) |
0.8 | 3.9 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.8 | 0.8 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.8 | 1.5 | GO:1990188 | euchromatin binding(GO:1990188) |
0.8 | 2.3 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.8 | 2.3 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.8 | 7.7 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.8 | 7.7 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.8 | 7.7 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.8 | 3.8 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.8 | 3.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.8 | 3.8 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.8 | 42.3 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.8 | 2.3 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.8 | 9.0 | GO:0004787 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.7 | 1.5 | GO:0036033 | mediator complex binding(GO:0036033) |
0.7 | 3.0 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.7 | 0.7 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.7 | 1.5 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.7 | 4.4 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.7 | 1.5 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.7 | 1.5 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.7 | 13.9 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.7 | 3.7 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.7 | 8.1 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.7 | 1.5 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.7 | 2.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.7 | 9.5 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.7 | 0.7 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.7 | 9.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.7 | 2.2 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.7 | 2.2 | GO:0019956 | chemokine binding(GO:0019956) |
0.7 | 6.4 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.7 | 3.5 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.7 | 4.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.7 | 2.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.7 | 4.2 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.7 | 10.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.7 | 1.4 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.7 | 2.7 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.7 | 4.8 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.7 | 54.6 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.7 | 2.7 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.7 | 10.2 | GO:0001848 | complement binding(GO:0001848) |
0.7 | 1.4 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.7 | 0.7 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) |
0.7 | 0.7 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.7 | 6.1 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.7 | 3.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.7 | 2.0 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.7 | 6.7 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.7 | 3.3 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.7 | 7.3 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.7 | 4.7 | GO:0034847 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.7 | 9.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.7 | 0.7 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.7 | 2.0 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.7 | 0.7 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.7 | 3.3 | GO:0015288 | porin activity(GO:0015288) |
0.7 | 1.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.7 | 1.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.7 | 4.6 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.7 | 2.0 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.7 | 1.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.7 | 5.9 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.6 | 2.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.6 | 2.6 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.6 | 5.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.6 | 13.4 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.6 | 1.9 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.6 | 5.7 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.6 | 1.9 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.6 | 2.5 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.6 | 1.2 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.6 | 1.2 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.6 | 3.1 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.6 | 7.9 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.6 | 3.0 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.6 | 2.4 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.6 | 1.8 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.6 | 3.0 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.6 | 1.8 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.6 | 9.6 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.6 | 3.6 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.6 | 3.6 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.6 | 0.6 | GO:0032190 | acrosin binding(GO:0032190) |
0.6 | 10.7 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.6 | 5.4 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.6 | 12.4 | GO:0005537 | mannose binding(GO:0005537) |
0.6 | 2.9 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.6 | 8.2 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.6 | 5.9 | GO:0005542 | folic acid binding(GO:0005542) |
0.6 | 11.7 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.6 | 2.3 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.6 | 3.5 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.6 | 9.9 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.6 | 2.3 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.6 | 4.1 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.6 | 6.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.6 | 10.4 | GO:0018452 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) mevaldate reductase activity(GO:0004495) gluconate dehydrogenase activity(GO:0008875) epoxide dehydrogenase activity(GO:0018451) 5-exo-hydroxycamphor dehydrogenase activity(GO:0018452) 2-hydroxytetrahydrofuran dehydrogenase activity(GO:0018453) acetoin dehydrogenase activity(GO:0019152) phenylcoumaran benzylic ether reductase activity(GO:0032442) D-xylose:NADP reductase activity(GO:0032866) L-arabinose:NADP reductase activity(GO:0032867) D-arabinitol dehydrogenase, D-ribulose forming (NADP+) activity(GO:0033709) (R)-(-)-1,2,3,4-tetrahydronaphthol dehydrogenase activity(GO:0034831) 3-hydroxymenthone dehydrogenase activity(GO:0034840) very long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0035380) (R)-2-hydroxyisocaproate dehydrogenase activity(GO:0043713) L-arabinose 1-dehydrogenase (NADP+) activity(GO:0044103) L-xylulose reductase (NAD+) activity(GO:0044105) 3-ketoglucose-reductase activity(GO:0048258) D-arabinitol dehydrogenase, D-xylulose forming (NADP+) activity(GO:0052677) |
0.6 | 1.7 | GO:0008430 | selenium binding(GO:0008430) |
0.6 | 2.9 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.6 | 2.9 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.6 | 64.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.6 | 1.7 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.6 | 2.3 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.6 | 0.6 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.6 | 1.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.6 | 5.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.6 | 0.6 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.6 | 2.8 | GO:0034452 | dynactin binding(GO:0034452) |
0.6 | 6.1 | GO:0034843 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.6 | 5.6 | GO:0030955 | potassium ion binding(GO:0030955) |
0.6 | 4.5 | GO:0017166 | vinculin binding(GO:0017166) |
0.6 | 5.0 | GO:0003796 | lysozyme activity(GO:0003796) |
0.6 | 10.6 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.6 | 5.0 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.6 | 4.4 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.6 | 1.7 | GO:0000182 | rDNA binding(GO:0000182) |
0.6 | 10.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.5 | 1.6 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.5 | 1.6 | GO:0019002 | GMP binding(GO:0019002) |
0.5 | 3.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.5 | 4.4 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.5 | 1.6 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.5 | 1.6 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.5 | 5.9 | GO:0001618 | virus receptor activity(GO:0001618) |
0.5 | 2.1 | GO:0070728 | leucine binding(GO:0070728) |
0.5 | 1.6 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.5 | 1.6 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.5 | 3.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.5 | 4.7 | GO:0004568 | chitinase activity(GO:0004568) |
0.5 | 1.6 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.5 | 3.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.5 | 1.6 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.5 | 0.5 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.5 | 0.5 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.5 | 25.8 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.5 | 1.0 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.5 | 1.0 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.5 | 11.0 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.5 | 28.0 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.5 | 6.5 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.5 | 2.0 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.5 | 14.7 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.5 | 3.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.5 | 0.5 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.5 | 2.9 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.5 | 3.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.5 | 6.3 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.5 | 4.8 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.5 | 1.4 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.5 | 3.8 | GO:0031491 | nucleosome binding(GO:0031491) |
0.5 | 1.4 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.5 | 1.9 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.5 | 2.8 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.5 | 2.3 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.5 | 4.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.5 | 1.4 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.5 | 7.8 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.5 | 2.8 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.5 | 2.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.5 | 1.8 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.5 | 10.0 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.5 | 12.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.5 | 0.9 | GO:0035276 | ethanol binding(GO:0035276) |
0.4 | 0.9 | GO:0031013 | troponin I binding(GO:0031013) |
0.4 | 1.3 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.4 | 0.4 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.4 | 1.3 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.4 | 1.8 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.4 | 6.2 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.4 | 13.3 | GO:0052767 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.4 | 2.2 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.4 | 0.9 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.4 | 13.6 | GO:0019843 | rRNA binding(GO:0019843) |
0.4 | 0.4 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.4 | 8.3 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.4 | 1.7 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.4 | 0.4 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.4 | 1.3 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.4 | 12.1 | GO:0016749 | succinyltransferase activity(GO:0016748) N-succinyltransferase activity(GO:0016749) |
0.4 | 3.4 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.4 | 10.3 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.4 | 6.4 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.4 | 0.8 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.4 | 6.4 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.4 | 0.4 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.4 | 2.5 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.4 | 32.1 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.4 | 68.0 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.4 | 1.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.4 | 2.1 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.4 | 0.8 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.4 | 1.7 | GO:0019808 | polyamine binding(GO:0019808) |
0.4 | 4.2 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.4 | 0.4 | GO:0015250 | water transmembrane transporter activity(GO:0005372) water channel activity(GO:0015250) |
0.4 | 1.2 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.4 | 0.8 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.4 | 5.3 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) sulfate transmembrane transporter activity(GO:0015116) |
0.4 | 0.8 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.4 | 3.2 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.4 | 1.6 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.4 | 1.6 | GO:0043515 | kinetochore binding(GO:0043515) |
0.4 | 0.4 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.4 | 6.7 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.4 | 2.0 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.4 | 10.6 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.4 | 20.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.4 | 11.0 | GO:0061650 | ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.4 | 1.6 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.4 | 1.2 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.4 | 1.6 | GO:1990405 | protein antigen binding(GO:1990405) |
0.4 | 3.1 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.4 | 1.2 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.4 | 1.9 | GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0033764) |
0.4 | 1.5 | GO:0035197 | siRNA binding(GO:0035197) |
0.4 | 0.8 | GO:0043426 | MRF binding(GO:0043426) |
0.4 | 1.9 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.4 | 8.3 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.4 | 1.1 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.4 | 1.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.4 | 4.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.4 | 1.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.4 | 2.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.4 | 2.6 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.4 | 11.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.4 | 1.5 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.4 | 0.7 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.4 | 0.7 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.4 | 1.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.4 | 0.7 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.4 | 1.1 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) calcium-dependent protein kinase regulator activity(GO:0010858) |
0.4 | 13.0 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.4 | 0.7 | GO:0019961 | interferon binding(GO:0019961) |
0.4 | 3.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.4 | 1.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.4 | 2.2 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.4 | 0.4 | GO:0035870 | dITP diphosphatase activity(GO:0035870) |
0.4 | 0.4 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.4 | 3.9 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.4 | 0.7 | GO:0000339 | RNA cap binding(GO:0000339) |
0.4 | 0.4 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.4 | 15.5 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.4 | 1.1 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.4 | 2.8 | GO:0030371 | translation repressor activity(GO:0030371) |
0.4 | 1.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.4 | 10.2 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.4 | 0.4 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.3 | 0.7 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.3 | 3.8 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.3 | 1.4 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.3 | 2.4 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.3 | 1.0 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.3 | 2.0 | GO:0005113 | patched binding(GO:0005113) |
0.3 | 1.0 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.3 | 1.0 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.3 | 1.0 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.3 | 9.7 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.3 | 9.4 | GO:0051087 | chaperone binding(GO:0051087) |
0.3 | 3.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.3 | 2.3 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.3 | 0.3 | GO:0001846 | opsonin binding(GO:0001846) |
0.3 | 0.3 | GO:0050693 | LBD domain binding(GO:0050693) |
0.3 | 0.7 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.3 | 1.6 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.3 | 4.6 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.3 | 1.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.3 | 9.8 | GO:0005507 | copper ion binding(GO:0005507) |
0.3 | 1.6 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.3 | 1.0 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.3 | 1.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.3 | 3.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.3 | 0.6 | GO:0016151 | nickel cation binding(GO:0016151) |
0.3 | 1.9 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.3 | 1.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.3 | 2.5 | GO:0046977 | TAP binding(GO:0046977) |
0.3 | 2.5 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.3 | 7.0 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.3 | 1.3 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.3 | 1.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.3 | 7.3 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.3 | 2.5 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.3 | 0.6 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.3 | 0.6 | GO:0043199 | sulfate binding(GO:0043199) |
0.3 | 2.8 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.3 | 7.7 | GO:0043022 | ribosome binding(GO:0043022) |
0.3 | 2.8 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.3 | 6.1 | GO:0000049 | tRNA binding(GO:0000049) |
0.3 | 0.6 | GO:0005534 | galactose binding(GO:0005534) |
0.3 | 0.3 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.3 | 1.2 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.3 | 2.7 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.3 | 1.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.3 | 1.8 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.3 | 0.9 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.3 | 9.8 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.3 | 2.7 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.3 | 0.6 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.3 | 4.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.3 | 2.6 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.3 | 0.9 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.3 | 1.2 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.3 | 0.9 | GO:0016726 | aldehyde oxidase activity(GO:0004031) xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.3 | 9.0 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.3 | 1.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.3 | 0.6 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.3 | 2.9 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.3 | 40.4 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.3 | 2.0 | GO:0048185 | activin binding(GO:0048185) |
0.3 | 0.6 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.3 | 1.7 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.3 | 0.6 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.3 | 1.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.3 | 24.9 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.3 | 0.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.3 | 12.5 | GO:0008565 | protein transporter activity(GO:0008565) |
0.3 | 1.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.3 | 7.2 | GO:0016875 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.3 | 5.4 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.3 | 1.8 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.3 | 16.6 | GO:0005178 | integrin binding(GO:0005178) |
0.3 | 0.8 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.2 | 13.9 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.2 | 0.5 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.2 | 10.1 | GO:0019003 | GDP binding(GO:0019003) |
0.2 | 0.5 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.2 | 1.9 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.2 | 0.7 | GO:0030515 | snoRNA binding(GO:0030515) |
0.2 | 8.6 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.2 | 4.3 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.2 | 1.9 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.2 | 1.9 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.2 | 2.3 | GO:0071949 | FAD binding(GO:0071949) |
0.2 | 5.6 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.2 | 0.2 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.2 | 2.8 | GO:0051536 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.2 | 0.7 | GO:0055100 | adiponectin binding(GO:0055100) |
0.2 | 13.2 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.2 | 0.7 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.2 | 5.3 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.2 | 4.0 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.2 | 0.4 | GO:0051373 | FATZ binding(GO:0051373) |
0.2 | 1.8 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.2 | 9.8 | GO:0004004 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.2 | 0.2 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.2 | 0.7 | GO:0004527 | exonuclease activity(GO:0004527) |
0.2 | 1.9 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.2 | 0.6 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.2 | 1.3 | GO:0070402 | NADPH binding(GO:0070402) |
0.2 | 1.3 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.2 | 33.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.2 | 0.2 | GO:0016428 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.2 | 19.9 | GO:0043774 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
0.2 | 0.6 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.2 | 1.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 1.6 | GO:0005048 | signal sequence binding(GO:0005048) |
0.2 | 1.0 | GO:0048038 | quinone binding(GO:0048038) |
0.2 | 1.8 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.2 | 1.6 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.2 | 0.8 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.2 | 0.4 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 2.4 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.2 | 0.2 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.2 | 1.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.2 | 1.8 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.2 | 0.2 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 0.2 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.2 | 0.6 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.2 | 0.6 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.2 | 0.2 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.2 | 0.8 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.2 | 0.4 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.2 | 0.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.2 | 0.6 | GO:0016208 | AMP binding(GO:0016208) |
0.2 | 0.6 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.2 | 1.3 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.2 | 0.2 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.2 | 0.2 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.2 | 0.9 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.2 | 1.4 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.2 | 0.3 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.2 | 3.0 | GO:0016209 | antioxidant activity(GO:0016209) |
0.2 | 0.3 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.2 | 1.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 2.2 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.2 | 0.8 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 1.0 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.2 | 0.8 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.2 | 1.0 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.2 | 4.6 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.2 | 3.3 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.2 | 0.6 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.2 | 4.1 | GO:0060090 | binding, bridging(GO:0060090) |
0.2 | 0.8 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.2 | 2.8 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.2 | 0.5 | GO:0016894 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
0.2 | 4.0 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.2 | 1.2 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.2 | 0.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.4 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 0.4 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.1 | 0.3 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.1 | 0.9 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.1 | 3.3 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 5.6 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 0.3 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.1 | 0.1 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.1 | 1.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.4 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.3 | GO:0060229 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
0.1 | 1.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.6 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.8 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 1.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.4 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.1 | 3.2 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.3 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 4.8 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.3 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 1.4 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 2.6 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.6 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 10.4 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.1 | 0.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 0.1 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.1 | 0.6 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.9 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.1 | GO:0030580 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
0.1 | 0.9 | GO:0009975 | cyclase activity(GO:0009975) |
0.1 | 0.1 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.1 | 0.9 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.8 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.6 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.1 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.5 | GO:0019239 | deaminase activity(GO:0019239) |
0.1 | 1.3 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.1 | 0.1 | GO:0070568 | RNA guanylyltransferase activity(GO:0008192) guanylyltransferase activity(GO:0070568) |
0.1 | 0.2 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.1 | 0.8 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.1 | 0.9 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.1 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.1 | 0.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 2.2 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 0.1 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.1 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 0.7 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 1.3 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 0.3 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 9.1 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.1 | 0.4 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 1.1 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 2.2 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 1.0 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.2 | GO:0051379 | epinephrine binding(GO:0051379) |
0.1 | 0.2 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 2.4 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 1.8 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 0.1 | GO:1904680 | peptide transmembrane transporter activity(GO:1904680) |
0.1 | 0.1 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.1 | 0.3 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.1 | 0.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 0.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.5 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.1 | 1.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.1 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 0.3 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 1.5 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 0.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.1 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.1 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 0.7 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.1 | 0.8 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.1 | 31.7 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.1 | 2.5 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 1.8 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.1 | 2.0 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.2 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.4 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.6 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 1.4 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.1 | 0.3 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.2 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.0 | 0.8 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.1 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 1.1 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.0 | 0.9 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 0.3 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.1 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.7 | GO:0019209 | kinase activator activity(GO:0019209) |
0.0 | 0.1 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 0.1 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.0 | 0.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.0 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.0 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.0 | 0.0 | GO:0035173 | histone kinase activity(GO:0035173) |
0.0 | 28.7 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.2 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.0 | 1.5 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.0 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.0 | 0.1 | GO:0045182 | translation regulator activity(GO:0045182) |
0.0 | 0.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 2.2 | GO:0016887 | ATPase activity(GO:0016887) |
0.0 | 0.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.1 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.0 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.0 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.1 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.0 | 0.0 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 0.3 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 4.4 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
2.7 | 23.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
2.6 | 2.6 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
2.4 | 33.7 | PID IL5 PATHWAY | IL5-mediated signaling events |
2.1 | 56.8 | PID EPO PATHWAY | EPO signaling pathway |
1.9 | 21.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
1.7 | 41.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
1.7 | 75.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
1.7 | 6.9 | PID CD40 PATHWAY | CD40/CD40L signaling |
1.5 | 39.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
1.4 | 39.7 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
1.4 | 14.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
1.4 | 1.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
1.3 | 2.7 | PID S1P S1P4 PATHWAY | S1P4 pathway |
1.3 | 37.7 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
1.3 | 43.6 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
1.3 | 15.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
1.3 | 28.8 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
1.2 | 16.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
1.2 | 63.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
1.2 | 46.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
1.2 | 5.8 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.1 | 36.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
1.1 | 2.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
1.1 | 6.7 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
1.1 | 12.3 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
1.1 | 2.2 | ST STAT3 PATHWAY | STAT3 Pathway |
1.1 | 61.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
1.1 | 38.2 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
1.0 | 7.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
1.0 | 4.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.9 | 1.9 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.9 | 43.2 | PID P73PATHWAY | p73 transcription factor network |
0.9 | 6.5 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.9 | 29.9 | PID PLK1 PATHWAY | PLK1 signaling events |
0.9 | 9.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.9 | 3.7 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.9 | 10.0 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.9 | 2.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.8 | 22.8 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.8 | 2.5 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.8 | 20.8 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.8 | 4.9 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.8 | 28.5 | PID E2F PATHWAY | E2F transcription factor network |
0.8 | 28.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.8 | 16.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.8 | 4.8 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.8 | 0.8 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.8 | 2.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.8 | 34.8 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.8 | 17.3 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.8 | 9.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.8 | 2.3 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.7 | 2.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.7 | 5.1 | PID MYC PATHWAY | C-MYC pathway |
0.7 | 4.4 | PID ATR PATHWAY | ATR signaling pathway |
0.7 | 9.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.7 | 19.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.7 | 13.1 | PID BARD1 PATHWAY | BARD1 signaling events |
0.7 | 10.4 | PID RAS PATHWAY | Regulation of Ras family activation |
0.6 | 2.5 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.6 | 13.2 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.6 | 1.9 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.6 | 17.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.6 | 9.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.6 | 12.1 | PID ARF6 PATHWAY | Arf6 signaling events |
0.6 | 4.8 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.6 | 16.2 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.6 | 17.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.6 | 4.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.6 | 21.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.6 | 5.2 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.6 | 5.6 | PID AURORA A PATHWAY | Aurora A signaling |
0.5 | 5.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.5 | 1.6 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.5 | 10.0 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.5 | 2.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.5 | 21.0 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.5 | 0.5 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.5 | 4.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.5 | 1.4 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.5 | 5.7 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.5 | 5.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.5 | 1.8 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.4 | 0.4 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.4 | 6.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.4 | 4.7 | PID ATM PATHWAY | ATM pathway |
0.4 | 0.8 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.4 | 1.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.4 | 1.6 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.4 | 1.6 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.4 | 6.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.4 | 3.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.4 | 2.8 | ST GAQ PATHWAY | G alpha q Pathway |
0.4 | 11.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.4 | 5.8 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.4 | 3.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.4 | 1.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.4 | 1.9 | PID ALK1 PATHWAY | ALK1 signaling events |
0.4 | 4.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.4 | 4.0 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.4 | 3.9 | PID ARF 3PATHWAY | Arf1 pathway |
0.3 | 4.5 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.3 | 0.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.3 | 0.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.3 | 1.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.3 | 2.8 | PID BCR 5PATHWAY | BCR signaling pathway |
0.3 | 5.5 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.3 | 5.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.3 | 0.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 0.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.3 | 0.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.3 | 2.9 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.2 | 12.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.2 | 1.4 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.2 | 1.8 | PID INSULIN PATHWAY | Insulin Pathway |
0.2 | 41.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 1.7 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 1.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 3.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 4.2 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.2 | 3.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 1.7 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 2.2 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 2.3 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.2 | 0.3 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 0.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 3.7 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 1.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 1.0 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 2.8 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 0.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 1.3 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 0.9 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 0.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.2 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.3 | PID AURORA B PATHWAY | Aurora B signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.8 | 67.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
3.5 | 3.5 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
3.3 | 33.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
3.0 | 36.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
2.5 | 25.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
2.4 | 28.7 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
2.0 | 20.2 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
2.0 | 12.1 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
2.0 | 25.9 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
1.9 | 32.5 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
1.8 | 8.9 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
1.7 | 27.7 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.7 | 30.3 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
1.7 | 18.4 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
1.7 | 1.7 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
1.6 | 3.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
1.5 | 28.2 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
1.5 | 3.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
1.5 | 19.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
1.4 | 24.0 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
1.4 | 23.8 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
1.4 | 12.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
1.4 | 13.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
1.3 | 50.0 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
1.3 | 14.5 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
1.3 | 12.9 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
1.3 | 27.0 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
1.3 | 27.6 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
1.2 | 107.1 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
1.2 | 12.4 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
1.2 | 17.4 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
1.2 | 55.9 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
1.2 | 30.8 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
1.2 | 17.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
1.2 | 1.2 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
1.2 | 16.4 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
1.2 | 9.2 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
1.1 | 1.1 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
1.1 | 1.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
1.1 | 13.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
1.1 | 29.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
1.1 | 4.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
1.1 | 10.9 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
1.1 | 6.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
1.1 | 23.5 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
1.1 | 11.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
1.1 | 4.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
1.0 | 1.0 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
1.0 | 2.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
1.0 | 10.3 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
1.0 | 13.1 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
1.0 | 6.0 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
1.0 | 19.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
1.0 | 10.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
1.0 | 7.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.9 | 33.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.9 | 18.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.9 | 7.3 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.9 | 14.5 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.9 | 5.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.9 | 6.2 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.9 | 5.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.9 | 8.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.9 | 3.4 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.9 | 1.7 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.9 | 2.6 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.9 | 11.1 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.9 | 17.1 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.8 | 3.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.8 | 9.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.8 | 9.9 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.8 | 18.9 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.8 | 9.9 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.8 | 16.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.8 | 14.6 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.8 | 12.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.8 | 4.8 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.8 | 34.1 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.8 | 2.3 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.8 | 76.8 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.8 | 13.7 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.8 | 0.8 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.8 | 20.5 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.8 | 13.6 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.7 | 5.7 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.7 | 5.0 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.7 | 14.6 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.7 | 11.1 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.7 | 6.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.7 | 6.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.7 | 6.9 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.7 | 8.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.7 | 4.0 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.7 | 4.6 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.7 | 8.5 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.6 | 1.9 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.6 | 14.0 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.6 | 33.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.6 | 18.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.6 | 8.9 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.6 | 4.3 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.6 | 1.8 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.6 | 5.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.6 | 1.8 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.6 | 8.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.6 | 4.1 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.6 | 8.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.6 | 3.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.6 | 8.7 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.6 | 16.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.6 | 2.3 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.6 | 2.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.6 | 14.0 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.6 | 7.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.6 | 2.2 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.5 | 15.3 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.5 | 4.9 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.5 | 6.0 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.5 | 9.7 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.5 | 4.8 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.5 | 1.6 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.5 | 10.5 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.5 | 5.8 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.5 | 52.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.5 | 5.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.5 | 0.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.5 | 1.5 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.5 | 2.6 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.5 | 42.2 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.5 | 19.9 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.5 | 4.4 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.5 | 5.9 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.5 | 4.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.5 | 1.4 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.5 | 3.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.5 | 6.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.5 | 0.5 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.5 | 6.3 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.4 | 17.1 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.4 | 2.2 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.4 | 1.8 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.4 | 4.9 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.4 | 2.6 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.4 | 0.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.4 | 1.3 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.4 | 8.6 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.4 | 5.1 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.4 | 12.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.4 | 5.5 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.4 | 0.8 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.4 | 9.2 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.4 | 0.4 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.4 | 4.4 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.4 | 1.2 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.4 | 4.4 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.4 | 35.5 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.4 | 4.0 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.4 | 30.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.4 | 2.0 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.4 | 1.2 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.4 | 7.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.4 | 0.8 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.4 | 5.0 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.4 | 8.0 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.4 | 5.7 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.4 | 4.5 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.4 | 6.4 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.4 | 1.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.4 | 4.4 | REACTOME TRANSLATION | Genes involved in Translation |
0.3 | 5.7 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.3 | 2.7 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.3 | 0.7 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.3 | 5.2 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.3 | 2.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.3 | 1.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.3 | 4.7 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.3 | 3.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.3 | 0.6 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.3 | 2.3 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.3 | 0.8 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.3 | 1.7 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.3 | 9.0 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.3 | 1.1 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.3 | 0.3 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.3 | 1.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 27.3 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 2.2 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.2 | 1.0 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.2 | 2.7 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.2 | 2.7 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.2 | 8.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 4.7 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.2 | 0.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 5.2 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.2 | 2.6 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.2 | 4.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.2 | 4.3 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 5.4 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.2 | 1.9 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.2 | 3.2 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.2 | 22.2 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.2 | 2.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.2 | 1.6 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 1.5 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.2 | 4.7 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.2 | 3.1 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 3.6 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.2 | 1.4 | REACTOME OPSINS | Genes involved in Opsins |
0.2 | 0.8 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 3.0 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.2 | 1.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 3.8 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 1.7 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 1.7 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.1 | 0.1 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.1 | 0.5 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 0.3 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 0.5 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 0.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 0.1 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 0.2 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 0.3 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 0.1 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.1 | 0.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 0.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.6 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 0.6 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 1.3 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.1 | 0.3 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 0.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 0.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 0.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.1 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.2 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.0 | 0.1 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
0.0 | 0.2 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |